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Sonoporation, enhanced by ultrasound contrast agents has been explored as a promising 
non-viral technique to achieve gene transfection and targeting drug delivery in recent 
years. However, the short lifespan of traditional ultrasound contrast agents like Optison® 
microbubbles under moderate intensity ultrasound exposure limits their application. 
Liposomes, as drug carriers consisting of curved spherical closed phospholipid bilayer 
shells, have the following characteristics: 1) The ability to encapsulate and carry 
hydrophilic or hydrophobic molecules. 2) The biocompatibility with cell membranes. 3) 
The nanometer size and the relative ease of adding special ligands to their surface to 
target a specific disease site. 4) The stability in the blood stream. 5) Targeted ultrasound 
irradiation can induce rupture of liposomes letting the drug encapsulated in them leak out 
to achieve controlled release of the therapeutic agents at a certain concentration and a 
delivery rate. 
 
In this thesis, several liposome synthesis methods are presented. Liposomes synthesized 
in our laboratory were characterized acoustically and optically. Anti rabbit IgG 
conjugated with Alexafluor 647 was delivered into Jurkat cells in a suspension containing 
liposomes by 10 % duty cycle ultrasound tonebursts of 2.2 MHz (the in situ spatially 
averged and temporally averaged intensity, ISATA = 80W/cm2) with an efficiency of 13 %.  
It has been experimentally shown that liposomes may be an alternative stable agent to 
Optison® to cause sonoporation. Furthermore, a type of nanometer-sized liposome 
(<300nm) was synthesized to explore the feasibility of ultrasound-triggered release from 
drug encapsulated lipsomes. It has been demonstrated encapsulated fluorescence 
materials (FITC) can be released from liposomes with an average diameter of 210 nm 
when exposed to high intensity focused ultrasound (HIFU) at 1.142MHz (ISPTA= 900 
W/cm2). Rupture of relatively large liposomes (>100nm) and porelike defects in the 
membrane of small liposomes due to the excitation of HIFU were the main causes of the 
content release. The great enhancement of HIFU-mediated release in the nanometer-sized 
liposomes may prove useful for clinical applications. 
 
The presence of fine particles in Martian and lunar soil poses a significant threat to 
NASA’s viable long-term exploration and habitation of either the moon or Mars. It has 
been experimentally shown that the acoustic levitating radiation force produced by a 13.8 
kHz 128 dB sound-level standing wave between a 3 cm-aperture acoustic tweeter and a 
reflector separated by 9 cm is strong enough to overcome the van der Waals adhesive 
force between the dust-particles and the reflector-surface. The majority of fine particles 
(> 2μm diameter) on a reflector surface can be dislodged and removed by a technique 
combining acoustic levitation and airflow methods. This dust removal technique may be 
used in space-stations or other enclosures for habitation. 
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CHAPTER 1  
COMPREHENSIVE LITERATURE REIVEW  
1.1 Organization of dissertation and introduction 
This dissertation is composed of five chapters. 
In chapter 1, a brief review of the current techniques of viral and non-viral gene 
transfection and targeting drug delivery is presented. Sonoporation, a promising non-viral 
technique using ultrasound to achieve gene transfection and targeting drug delivery with 
spatial and temporal specificity is introduced. Possible mechanisms and in vitro 
applications of sonoporation in DNA, anticancer drug and antibody deliveries are 
discussed. The structure and characteristics of liposomes have been reviewed. The 
motivation of applying liposomes to sonoporation is illustrated. In addition to the 
biomedical applications of acoustics, concept of acoustic levitation and its potential 
application to NASA’s dust removal project are presented.  
Chapter 2 is a paper that describes an experiment of application of liposomes to 
sonoporation. A method of liposome production and the characterization of the liposome 
products are introduced. It has been experimentally shown that liposomes synthesized in 
our laboratory were quite stable under the sonication and liposomes like Optison® (GE 
Healthcare, Princeton, NJ, USA) were able to assist ultrasound to deliver antibodies into 
Jurkart cells. This paper suggests that liposomes may be an alternative stable agent to 
Optison® to cause sonoporation.   
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Chapter 3 is a journal paper to explore the feasibility of ultrasound-triggered release 
from drug encapsulated lipsomes. A type of nanometer-sized liposome (<300nm) was 
synthesized. Liposomes loaded with a fluorescence agent (FITC) were irradiated by high 
intensity focused ultrasound (HIFU) ultrasound in a well defined manner. The kinetics of 
release, the size distribution change and physical integrity of the irradiated liposomes 
were analyzed by using dynamic light scattering technique and transmission electron 
microscopy (TEM). It has been demonstrated encapsulated fluorescence materials (FITC) 
can be released from liposomes with an average diameter of 210 nm when exposed to US 
at 1.142MHz (the spatial peak and temporal average intensity, ISPTA= 900 W/cm2). 
Rupture of relatively large liposomes (>100nm) and porelike defects in the membrane of 
small liposomes due to the excitation of HIFU were the main causes of content release. 
The great enhancement of HIFU-mediated release in the nanometer-sized liposomes may 
prove useful for clinical applications. 
In Chapter 4, a feasibility study to develop a dust removal technique, which may be 
used in space-stations or other enclosures for NASA’s long-term project (i. e., exploration 
and habitation of the moon and Mars) is reported. It is shown experimentally that the 
acoustic levitating radiation force produced by a 13.8 kHz 128 dB sound-level standing 
wave between a 3 cm-aperture tweeter and a reflector separated by 9 cm is strong enough 
to overcome the van der Waals adhesive force between the dust-particles and the 
reflector-surface. Thus the majority of fine particles (> 2 μm diameter) on a reflector 
surface can be dislodged and removed by a technique combining acoustic levitation and 
airflow methods. The removal efficiency deteriorates for particles of less than 2 μm in 
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size.   
Summary and conclusions are made in the last chapter. 
1.2 Sonoporation, liposome and targeting drug delivery 
1.2.1 Sonoporation, gene transfection and targeting drug delivery using ultrasound 
1.2.1.1 Gene transfection and targeting drug delivery 
Targeting drug and DNA delivery technique is potentially an important technologies 
in modern medicine.  An ideal in vivo technique should be able to deliver 
macromolecules, including pharmaceutical drugs, antibodies or DNA to their specific site 
of action. For pharmaceutical drug and antibodies, the dosage delivered should be at 
therapeutically relevant levels. Targeting delivery offers enormous advantages compared 
with conventional deliveries. For example, since conventional methods lack target 
specificity, some highly toxic anticancer drugs delivered conventionally may severely 
damage healthy tissues and organs undesirably. Targeting delivery not only increases 
drug efficacy but also minimizes any possible side effect of the conventional delivery 
method.  
Transfection, a process of introducing recombinant DNA into eukaryotic cells 
(eukaryotic cells have chromosomes with nucleosomal structure) and subsequently 
integrating the DNA into the recipient cell’s chromosomal DNA (Anderson 1992), is the 
necessary step in all forms of genetic manipulation. Meanwhile, transfection is also a 
major limiting step because DNA is a large, highly charged molecule that cannot diffuse 
through the cell membrane effectively. The barriers from the cell membranes, as well as 
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from nuclear membranes for DNA, and also for antibodies and drugs if their targets are 
located in the cell nuclei are the major difficulties to targeting gene transfection and drug 
delivery. Current transfection protocols can be divided into two broad categories—viral 
and nonviral. The viral transfection techniques, as the name suggests, utilize viruses as 
vectors such as retroviruses and adenoviruses to achieve the goal as shown in Figure 1.1 
(Roberts et al. 2009). In order to replace a dysfunctional abnormal targeted protein, a 
gene transfer vector such as a disabled adenovirus is modified so that it contains the gene 
that encodes for this protein. Once the modified vector is delivered to the affected cells, 
the gene tranfer vector then transfers the therapeutic gene to the cell, and ideally the cell’s 
own machinery turns the therapeutic gene into correct version of the protein, which in 
essence fixes the dysfunctional cell. However, viral transfection techniques have 
drawbacks including its lack of spatially targeting  nature (no control over where the 
gene becomes transfected) and possible adverse side effects such as resistance to 
metabolic degradation and attack by the immune system. It is desirable to develop a 
controllable nonviral transfection technique to deliver macromolecules, including DNA, 
drug and other therapeutic agents, safely and efficiently into specific target sites in vivo as 
well in vitro. 
Forms of nonviral transfection are represented by lipofection, electroporation and 
particle bombardment. Lipofection or liposome transfection is one of the most widely 
used nonviral methods of transferring genetic material to living cells. Essentially, 
liposomes or phospholipid vesicles encapsulate the negatively charged DNA and 
facilitate transfer of the gene through the cell membrane (Gershon et al. 1993) The 
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application of liposome has shown great potential in gene transfection (Lasic 1993) 
because of its properties, and biocompatibility with cell membranes and the possible 
addition of special ligands on their surface. The lipofection method allows high 
transfection rates with minimal cellular toxicity, but as with the viral vectors, it does not 
allow control of spatial or temporal specificity of delivery. Electroporation uses 
high-voltage electrical pulses to make cell membranes transiently permeable permitting 
cellular uptake of foreign macromolecules (Chang et al. 1990). This method allows some 
spatial targeting, but requires electrode placement, which can be invasive. Particle 
bombardment represents yet another way of “injecting” foreign DNA into cells by 
coupling the gene to projectiles that are made to penetrate the membrane at high speed 
(Daniell 1993). This method also allows accurate placement of DNA delivery, but 
appears to be limited to surface applications. 
It has been demonstrated (Bao et al. 1997; Greenleaf et al., 1998; Lawrie et al. 2000; 
Lu et al. 2003; Miller et al. 1999; 2003; Ward et al. 1999; 2000; Wu et al. 2002; Wu et al. 
2006a) that ultrasound (US) assisted by encapsulated microbubbles (EMB) could make 
cell membranes temporarily open and deliver DNA and other macromolecules into cell 
nuclei and make affected cells transfected. Most EMB used in these applications belongs 
to ultrasound imaging contrast agents used clinically. The ultrasound technique associated 




Figure 1. 1. Diagram of gene therapy using an adenovirus vector from Roberts et al. 2009 
 
1.2.1.2 Sonoporation and its application in drug delivery 
As introduced above, sonoporation is a technique that utilizes ultrasound to enhance 
the permeability of the cell plasma membrane. With the presence of macromolecules, 
ultrasonically induced multiple surface pores on a cell (Figure 1.2) were first observed by 
Tachibana et al. (1999). The rapid process of cell membrane porosity during the 
sonication may even induce cell killing.   
On the other hand, delivery of both DNA and other macromolecules into affected 
cells under ultrasound excitation has been demonstrated by several investigators (Kim et 
al. 1996; Bao et al. 1997; Tata et al. 1997; Greeleaf et al. 1998; Mukherjee 2000). After 
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the identification of cavitation as the probable mechanism behind the increased cell 
permeability, and the demonstration of further enhancement of transfection efficiency by 
using cavitation nuclei, such as encapsulated microbubbles (Bao et al. 1997; Greeleaf et 
al. 1998; Porter et al. 1996; Lawrie et al. 2000), sonoporation has gained considerable 
researchers’ attention as a promising technique for targeting gene transfer and drug 
delivery. 
There was an experimental study performed to compare cell viability and 
transfection efficiency between sonoporation and electroporation for cell suspensions 
(Pepe et al. 2004). The electroporation was performed using a Gene Pulser® II Apparatus 
(BIO-RAD, Hercules, CA, USA) with optimum voltage of 250 V, and the sonoporation 
was achieved by using 2 MHz pulsed ultrasound exposure (the spatial average and 
temporal average intensity, ISATA = 80 W/cm2) assisted with Optison®, a type of 
encapsulated bubbles commercially obtained (GE Healthcare, Princeton, NJ, USA). It 
was shown that significantly more human peripheral blood mononuclear cells (PBMC) 
(primary cells) survived after sonoporation (64.8% ± 1.51%) for “PULSE US, GFP (GFP 
is a green fluorescent protein used as a marker to detect fluorescent cells.)” than 
electroporation (53.7% ± 1.53%); significantly (P < 0.015) more PBMC showed 
fluorescence (successful transfection) after sonoporation (2.73% ± 0.21%) than 
electroporation (0.43% ± 0.06%) (Table 1.1). Considering that the transfection efficiency, 
which may be defined as the number of cells transfected divided by the number of cells 
surviving the treatment, the transfection efficiency of sonoporation in regard to the initial 
number of cells is even higher than that of electroporation. 
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Table 1. 1. Comparison of transfection and viability of PBMC between electroporation and 
sonoporation. 
 PULSE US, No GFP PULSE US, GFP Electrical, GFP 
Fluorescent (%) 
Viability (%) 
0.13 ± 0.06 
63.0 ± 0.84 
2.73 ± 0.21 
64.8 ± 1.51 
0.43 ± 0.06 
53.7 ± 1.53 
 
 
Figure 1. 2. Scanning electron microscopic images of HL-60 cells. Irradiated with ultrasound in 
the presence of MC 540 (A to D), untreated intact cells (E), cells irradiated with ultrasound 




Figure 1. 3. Pictures taken from a confocal microscope (objective x 60) (Bio Rad, MRC 1024 ES 
CLSM, Hercules, CA) show that anti mouse IgD conjugated with fluorescein 
isothyocyanate-dextran (FITC) was delivered into Jurkat lymphocytes. A picture on the left is 
for a control case (sham-exposure) and that on the right is for a case after sonoporation. 
 
Figure 1. 4. Pictures taken from a confocal microscope (objective x 60) (Bio Rad, MRC 1024 ES 
CLSM, Hercules, CA) show that anti mouse IgD conjugated with fluorescein 
isothyocyanate-dextran (FITC) was delivered into PBMC. A picture on the left is for a control 
case (sham-exposure) and that on the right is for a case after sonoporation. 
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Furthermore, instead of delivery of plasmid DNA into cell nuclei, antibodies such as 
anti-rabbit IgG conjugated with fluorophore (Alexafluor 647, Molecular Probes, Eugene, 
Oregon), anti-mouse IgD conjugated with fluorescein isothyocyanate-dextran (FITC, 
Pharmingen, San Diego, CA) were delivered into the cytoplasm of PBMC and Jurkat 
lymphocytes in a following study (Wu et al. 2006a). Fluorophore (Alexafluor 647) and 
FITC were used as markers for detection of the success of the antibody delivery. Pictures 
taken from a confocal microscope show that anti mouse IgD conjugated with fluorescein 
isothyocyanate-dextran (FITC) was successfully delivered into Jurkat lymphocytes 
(Figure 1.3) and PBMC (Figure 1.4) cells. The cell viability and delivery efficiency 
obtained using a flow cytometer are presented in Table 1.2 and 1.3. It has been shown 
that the sonoporation with the presence of Optison® dramatically increased the delivery 
efficiency while maintained excellent cell viability. 
Antibodies usually are hydrophobic and large in size; it has been a challenge to send 
them into the cytoplasm of a cell because of the protection of the cell membrane. For 
example IgG, the major immunoglobulin in human serum, has a molecular weight of 
150,000 Da and another immunoglobulin in the blood serum, IgD, has a molecular 
weight of 180,000 Da.  Antibodies play an essential role in immunity.  Antibodies are 
often used as clinical therapy to block the interaction of soluble molecules to their 
receptors and prevent the initiation of the signaling pathways triggered by the receptor. 
Antibodies can also be used to block intracellular pathways when they recognize proteins 
involved in signaling pathways, transcription factors, and cytoskeleton etc. The 
successful delivery of antibodies into cells achieved in this study suggests that 
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sonoporation may be a promising, non-invasive technique in delivering macromolecular 
antibodies and anticancer drugs into cells.   
Table 1. 2. Antibody Delivery Efficiency and Cell Viability for Jurkat Lymphocytes 
 NO US, Goat 
Anti Rabbit IgG 
US, Goat Anti 
Rabbit IgG 
NO US, Anti 
Mouse IgD 





1.60 ± 0.00 
 
87.2 ± 0.62 
78.60 ± 3.60 
 
81.1 ± 0.44 
1.33 ± 0.31 
 
92.0 ± 0.42 
34.9 ± 1.80 
 
65.7 ± 2.21 
  
Table 1. 3. Antibody Delivery Efficiency and Cell Viability for PBMC 
 NO US, Goat 
Anti Rabbit IgG 
US, Goat Anti 
Rabbit IgG 
NO US, Anti 
Mouse IgD 





11.3 ± 0.81 
 
81.1 ± 2.32 
57.5 ± 4.23  
 
61.1 ± 4.23 
1.66 ± 0.06 
 
67.9± 4.30 




Acoustically induced transfection via sonoporation in vitro uses ultrasonic waves of 
megahertz frequency to excite encapsulated microbubbles (EMB) such as Optison® 
microbubbles mixed with cells in a medium. EMB could oscillate moderately under the 
ultrasonic agitation (it is called non-inertial or stable cavitation), generating a shear stress 
on the cell membrane of a nearby cell. Microstreaming (a DC flow) as a result of 
noninertial cavitation may be established around an oscillating EMB (Gormley and Wu 
1998) facilitating the entrance of DNA into a cell (Wu et al. 2002). EMB may also 
oscillate violently and collapse, experiencing inertial cavitation or transient cavitation 
(NCRP 2002). In both cases, as shown in Figure 1.5 (a) and (b), cell membranes of those 
cells in a medium may “open” for short time allowing foreign molecules or DNA to enter 





Figure 1. 5. Destruction of microbubbles by ultrasound resulting in increased membrane 
permeability by shear stress, temperature rise and activation of reactive oxygen species. Drug 
delivery by microbubbles by: (a) transient holes induced by shear stress; (b) increase in 
membrane fluidity; (c) endocytosis of microbubbles; (d) fusion of the microbubble membrane 
with the cell membrane. Adapted from Dijkmans et al. 2004. 
 
The use of non-inertial cavitation is much more controllable than the inertial 
cavitation and generates less non-reparable sonoporated cells. Particularly, in targeting 
drug and gene delivery in vitro and in vivo experiments, it has been demonstrated that 
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EMB excited by moderate intensity US can increase permeability of cell membranes 
allowing gene, therapeutic drugs and antibodies to enter cells (Unger et al. 2001; 2002; 
Miller 2006; Tachibana & Tachibana 2006; Wu 2006) with the affected cells remaining 
viable. This process is now called reparable sonoporation.  Tran et al. (2007) have 
performed an in vitro experiment using the ruptured-patch-clamp whole-cell technique. 
They demonstrated the hyperpolarization of the membrane of a marked cell (mammary 
breast cancer cell line MDA-MB-231) during sonoporation (1 MHz, 0.15 MPa negative 
peak US; Sono Vue microbubbles were used). The hyperpolarization of a cell means an 
above-normal increase in the trans-membrane voltage. They concluded that ultrasound 
activated oscillations of EMB modify the electro-physiologic cell activities by their 
“cellular massage” action and thus enhance the cell’s permeability toward macroparticle 
uptake. “Cellular massage” here may mean the actions on a cell through the moderate 
shear stress generated by nearby oscillating bubbles.  
Another recent study applied the scanning electron microscopy (SEM) to investigate 
the sonoporation effects on the cell membrane (Qiu et al. 2010). It was found that with 
the increasing of ultrasound parameters, or inertial cavitation dose (higher acoustic peak 
negative pressure amplitude (P-), longer treatment time, or faster 
pulse-repetition-frequency (PRF)), larger sonoporation pores and more rough regions 
were generated on the cell membranes as shown by SEM images (Figure 1.6).  The 
sonoporation pore sizes measured according to SEM images as a function of acoustic 
peak negative pressure amplitude are plotted in Figure 1.7. It can be noticed that the 
sonoporation pore size increases with the increasing of P−, treatment time and PRF. They 
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also observed that ultrasound mediated DNA transfection efficiency with the presence of 
ultrasound contrast agents was dramatically enhanced as shown in Figure 1.8. Their 
results suggested sonoporation pores on the cell membrane could be highly correlated 
with inertial cavitation dose and inertial cavitation activities accumulated during 
ultrasound exposure should play an important role in the ultrasound-mediated DNA 
transfection through sonoporation. Moreover, quantified inertial cavitation could be used 
as an effective tool to monitor and control the ultrasound-mediated gene or drug delivery 
effect. 
These findings opened tremendous opportunities for application of sonoporation in 
the field of targeting drug delivery and gene transfer. Conceptually, DNA, pharmaceutical 
drugs or other macromeolecules mixed with ultrasound contrast agents could be injected 
intravenously, and targeting delivery of drug could be achieved by selective insonation of 
a predefined area as demonstrated in Figure 1.9. Sonoporation, though it is a relative new 
comer in gene transfer and drug delivery, has been a promising modality that combines 
the capability of enhancing delivery efficiency with the possibility to allow control of 





Figure 1. 6. Morphology of cells exposed to 20-cycle US pulses at 1 MHz, with varied (a), 
acoustic pressure (P−), (b) US treatment time, and (c) PRF. The white arrows point out some 
sonoporation pores. Adapted from Qiu et al. 2010 
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Figure 1. 7. The influences of US parameters on sonoporation pore size. (a) The sonoporation 
pore sizes measured according to SEM images are plotted as a function of P−, with PRF=250 Hz, 
treatment time=20 s; (b) pore size vs. treatment time, with P−=2.2 MPa, PRF=250 Hz; and (c) 
the relationship between pore size and PRF, with P−=2.2 MPa, treatment time=20 s. Adapted 
from Qiu et al. 2010 
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Figure 1. 8. Assessment of DNA transfection efficiency for the cells with (1) naked DNA, no US, 
(2) naked DNA and UCA, exposed to US, (3) PEI:DNA, no US, (4) PEI:DNA, exposed to US, and 
(5) PEI:DNA and UCA, exposed to US. US conditions: P−=2.2 MPa, 250-Hz PRF, and 20-s 
treatment time. Adapted from Qiu et al. 2010 
 
Figure 1. 9. Schematic representation of the ultrasound technique called sonoporation that will 
be researched by Philips and GlyGenix Therapeutics for the targeting delivery of genes. 
Sonoporation involves the use of microbubbles that are co-injected into the bloodstream along 
with the therapeutic genes. When they arrive at the target organ, the microbubbles are 
subjected to high-intensity focused ultrasound causing them to rupture. This increases the 
permeability of the blood vessel wall and cell walls in the underlying tissue and facilitates the 
local uptake of the therapeutic genes. Adapted from Philips Research Press Release (2009). 
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1.2.2 Application of liposomes to sonoporation in targeting drug delivery 
1.2.2.1 Liposome structure and characteristics . 
A liposome or phospholipid vesicle basically is a tiny bubble consisting of an 
aqueous core enclosed in one or more phospholipid layers. Liposomes were first 
described in 1965 by Bangham when he discovered that phospholipids in water form 
closed vesicles (Bangham 1965). They were initially used in the study of cellular 
membranes, as they are made from neutral phospholipids such as lecithin and cholesterol, 
the same materials to construct a cell membrane. Such lipids are amphipathic, meaning 
they have a head group and a tail group (Figure 1.10). The head is attracted to water, and 
the tail, which is made of a long hydrocarbon chain, is repelled by water. In nature, 
phospholipids are found in stable membranes composed of a bilayer as shown in Figure 
1.10. When placed in an appropriate environment and at specific concentrations, these 
membrane phospholipids can reassemble themselves into a spherical structure. The 
sphere is a closed bilayered vesicle as shown in Figure 1.11. The hydrophilic polar groups 
face the aqueous interior core, while the hydrophobic nonpolar portions are tucked into 
the interior of the membrane bilayer. This effectively results in two potential 
compartments to entrap a substance. The hydrophilic aqueous core can trap a hydrophilic 





Figure 1. 10. Left: A phosphlipid with a hydrophilic head and hydrophobic tails. Right: A lipid 





Figure 1. 11. A schematic of a liposome. Adapted from Encyclopædia Britannica 
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Liposomes can be manufactured with a diameter ranging from several nanometers to 
several micrometers. The size of liposomes varies according to their intended use. 
Liposomes in most current drug delivery applications have a diameter in the submicron 
range. This range is a compromise between the efficiency of loading, liposome stability 
and the ability of the liposome to extravasate from the vasculature. For example, large 
liposomes can be loaded relatively easily but tend to remain in blood vessels.  
1.2.2.2 Liposomes as a drug delivery system 
Another emerging non-viral delivery technique is to use a liposome as a carrier of 
DNA or drugs. For an optimal drug-carrier delivery system, the drug should be retained 
within a stable carrier, the carrier should be “invisible” to the reticuloendothelial system, 
and there should be a built in or controllable release mechanism for the drug. Ideally, the 
drug would localize directly and specifically at the intended targets, resulting in excellent 
therapeutic efficacy, with few or no adverse effects.  
Liposomes have been extensively investigated for their promise of being an ideal 
drug delivery system (Lasic et al. 1995). Conventional liposomes were composed of egg 
phosphatidylcholine and cholesterol (Lasic et al. 1995). When injected intravenously, 
plasma opsonins and lipoproteins coat the outer surface of these conventional liposomes. 
Subsequently, reticuloendothelial cells quickly phagocytize and remove these liposomes 
from circulation. The widespread enthusiasm for the use of liposomes as drug delivery 
systems were demonstrated after the discovery of a polyethylene glycol (PEG) derivative 
as a liposome coating. The new formulation of PEG-coated liposomes greatly extended 
liposome circulation times. These liposomes have been termed second-generation or 
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sterically stabilized liposomes because of their ability to evade phagocytosis by the 
reticuloendothelial system (Lasic et al. 1995). Sterically stabilized liposomes have the 
ability to remain in circulation up to 100x longer than conventional liposomes 
(Papahadjopoulos 1991). This is due to the ability of the PEG coating to form a steric 
barrier by attracting water to the liposome surface (Figure 1.12). The liposome surface 
becomes hydrophobic, resulting in enhanced stability by inhibiting interactions with 
plasma proteins such as opsonins and lipoproteins. Thus, PEG coated liposomes have a 
decreased affinity for the reticuloendothelial system. The ability of PEG coated 
liposomes to avoid rapid reticuloendothelial system uptake has led to their use in drug 
delivery systems for sustained drug release and selective delivery of encapsulated 
substances to specific target sites.  
In addition to the success and extensive use of PEGylation for surface modification 
of liposomes, research development is ongoing using different copolymers, crosslinking 
or polymerization of lipid bilayers, and molecular manipulation of the liposome surface 
to alter its behavior after injection. The most important biological consequence of these 
different surface modification substances and techniques is a significant increase in 
liposome circulation time and stability through the reticuloendothelial system. Hence, 
several liposomal formulations have been approved by the FDA as listed in Table 1.4 





Figure 1. 12. The structure of liposomal delivery systems. (a) Drug-containing liposomes in the 
absence of a polyethylene glycol (PEG) coating. Hydrophobic drug is present in the liposome 
membrane and hydrophilic drug is present in the liposome aqueous interior. Protein opsonins 
are shown absorbing to the ‘naked’ liposome surface. (b) PEG-coated liposome with entrapped 
drug in the liposome interior. Protein opsonins have significantly less absorption to the liposome 




Table 1. 4. Liposome and lipid-based products approved for clinical use in the United States 
Adapted from Lian, J Pharm Sci. Volume 90(6): 667–80. 2001 
 
Product Drug (lipid:drug 
ratio) 
















DSPC:Chol (2:1) Gilead Sciences 
(formerly 
NeXstar) 
Kaposl sarcoma in 
AIDS 












Amphotec™ Amphotericin B 
(1:1) 





Abelect™ Amphotericin B 
(1:1) 







The unique structural properties of liposomes also allow different methods to be 
used to entrap substances or drugs. Depending on the substance used, it will either be 
trapped while liposomes form spontaneously or the substance can be loaded into 
preformed liposomes. Substances with intermediate solubility can be loaded into the 
aqueous interior of existing liposomes by the use of ionic gradients or molecular 
complexes. It has been shown that water-soluble and water-insoluble materials can be 
encapsulated together in a liposome (Nii et al. 2005). Water-soluble materials are 
entrapped in the aqueous core, while water-insoluble and oil-soluble hydrophobic drugs 
reside within the lipid bilayer. The entrapped drug is protected from metabolism within 
the liposome interior and cannot be active or metabolized until released. The extended 
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circulation times of liposome may favorably alter the ultimate rate and pathway of drug 
metabolism. Several other ways of attachment of drugs to a liposome or a lipid coating 




Figure 1. 13. Several mechanisms to attach drugs to microbubbles. a: Incorporation in the 
bubble; b: incorporation in the bubble membrane; c: attachment to the membrane; d: 




Another interesting property of liposomes is their natural ability to target cancer 
cells. The endothelial wall of all healthy human blood vessels are encapsulated by 
endothelial cells that are bound together by tight junctions. These tight junctions stop any 
large particle in the bloodstream from leaking out of the vessel. Regions of solid tumor 
growth, infection and inflammation usually have capillaries with increased permeability 
(Gerlowski et al. 1986). 
Liposomes of certain sizes, typically less than 400nm, encapsulated with drugs can 
rapidly enter the interstitium of tumors from the blood, but are kept in the bloodstream by 
the endothelial wall in healthy tissue vasculature. Once in the tumor interstitial space, the 
liposomes are heterogeneously distributed throughout the tumor by diffusion and/or 
hydraulic convection (Gerlowski et al. 1986). It has been shown that not only does the 
PEG coating of liposomes increase circulation times but also allows greater extravasation 
than conventional liposomes, which enhances the accumulation of drug in diseased tissue 
by several fold compared to normal tissue.  
As for hematogenous tumors or metastatic cells in the blood or lymph where passive 
targeting cannot be done, liposomes coated with surface ligands would be especially 
useful (Lasic 1998; Allen 1994a; Lasic et al. 1995). Techniques used to attach the ligand 
to sterically stabilized liposomes include covalent attachment of antibody to the liposome 
surface, covalent attachment of antibody to liposome surface by end-functionalized PEG, 
and noncovalent binding of biotinylated antibody using an avidin linker (Allen 1994a). 
By using antibodies attached to sterically stabilized liposomes, it has been possible to 
specifically target cancers, both in vitro and in vivo (Allen 1994b ; Ahmad et al. 1992; 
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Ahmad et al. 1993; Pagnan et al. 2000; Park et al. 2002; Sapra et al. 2003). 
1.2.2.3 Sonoporation in drug delivery by using liposomes 
As indicated in the previous section, sonoporation might be a promising non-viral 
modality to fulfill gene transfection and drug delivery with spatial and temporal 
specificity. Sonoporation process is primarily caused by acoustic cavitation of 
encapsulated microbubbles, a mainly mechanical process, and can be non-lethal to cells.  
Delivery of macromolecules including DNA into cells by using ultrasound assisted 
by EMB such as Albunex® and Optison® has been demonstrated (Bao et al. 1997; 
Greenleaf et al. 1998; Miller et al. 1999; Ward et al. 1999; Lawrie et al. 2000; Ward et al. 
2000; Wu 2002; Lu et al. 2003; Miller et al. 2003). The Optison® spheres have been 
successfully used in therapeutic applications in addition to be a contrast agent. With the 
presence of Optison®, sonoporation effect has also been demonstrated for monolayer 
cells by a 3.5 MHz diagnostic ultrasound (Miller 2000). As mentioned previously, 
sonoporation assisted by Optison® is also effective to deliver antibodies and drugs into 
cells (Wu 2006). 
However, one shortcoming of Optison® is its fragility behavior under exposure of 
1-2 MHz ultrasound of a modest intensity (Wu et al. 1998). Optison® microspheres can be 
easily broken under exposure to ultrasound whose amplitude is as low as few hundred 
kilo-Pascals (Miller et al. 1999). 
As discussed previously, liposomes have been studied extensively for their promise 
of being an ideal drug delivery system. Used as a drug carrier, liposomes have the 
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following characteristics:  
1) The ability to encapsulate, protect and carry hydrophilic or hydrophobic 
molecules.  
2) The biocompatibility with cell membranes and biodegradability. 
3) The nanometer size and the relative ease of adding special ligands to their surface 
to target a specific disease site. 
4) The stability in the blood stream. 
5) Targeted ultrasound irradiation can induce rupture of liposomes letting drug 
encapsulated in liposomes leaking out from liposomes, to achieve controlled release of 
the therapeutic agents at a certain concentration and a delivery rate. 
Based on the unique properties of liposomes, we have considered them as a potential 
alternative to traditional ultrasound contrast agents like Optison® in the sonoporation 
applications. Our long-term goal is to use liposomes to enclose macromolecules such as 
drugs, DNA or antibodies and, under the irradiation of ultrasound, enhancing cell 
membrane permeability transiently allowing liposomes to enter cells. Under appropriate 
stimuli, the macromolecules can be released in a controllable manner to achieve targeting 
drug delivery into cells. 
In the work presented in Chapter 2, a method to synthesize liposome was introduced. 
Our liposome products were characterized acoustically and optically by using ultrasonic 
spectropscopy (Wu 1996) and dynamic light scattering techniques. Anti rabbit IgG 
conjugated with Alexafluor 647 was delivered into Jurkat cells in suspension using the 
liposomes composed of phosphatidylcholine, stearylamine, and cholesterol, by 10 % duty 
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cycle ultrasound tonebursts of 2.2 MHz (the in situ spatial average temporal average = 
80W/cm2) with an efficiency of 13 %.  It has been experimentally shown that liposomes 
may be an alternative stable agent to Optison® for delivering macromolecules into cells. 
1.2.3 Ultrasound-mediated drug release from nanometer liposomes 
Used as non-toxic, biodegradable and non-immunogenic drug delivery vehicles, 
ideally, liposomes should be able to carry an appropriate drug dose, remain stable in 
circulation (Bakker-Woudenberg 2002) and then release their drug contents such that the 
local concentration is high enough to mediate an effective therapeutic effect at the target 
site. Currently in cancer chemotherapy, liposomes loaded with cytotoxic drugs are used 
since they can take advantage of the higher permeability of tumor vasculature to 
extravasate at the desired site of action. The drug loaded liposomes appear to remain at 
the desired site long enough that the entrapped drug is able to leak from them and effect 
the destruction of tumor cells. 
To deliver a high local dose, it is desirable to release the therapeutic agents of a 
liposome more rapidly than passive transmembrane diffusion will allow. In the best case, 
rapid release triggered by a local stimulus could be an effective method of targeting a 
drug to a desired location. Although a number of methodologies for both drug 
encapsulation and prolonging the circulation of liposomes have been developed over past 
20 years (Kono 2001; Allen et al. 1991), few procedures are available for triggered drug 
release. Strategies for triggering drug release from liposomes have been proposed, 
including chemical approaches (Guo et al. 2003), biological approaches (Meers 2001), 
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and methods based on physical phenomena such as electric fields (Murdan 2003), 
magnetic fields (Babincova et al. 2002), temperature (Kono et al. 1999), visible light 
(Anderson et al. 1992; Mueller et al. 2000), pH (Drummond et al. 2000), and ultrasound 
(Marin et al. 2002). Ultrasound is of special interest in controlled release applications 
because ultrasound is non-invasive and yet is able to penetrate into the interior of the 
body. In addition, ultrasound can be focused on targeted sites and moreover has been 
shown to increase the permeability of blood–tissue barriers and cell membranes (Price et 
al. 1998). 
To enhance the drug delivery efficiency, the size of liposomes also plays a crucial 
role. It was demonstrated by Liu et al. (1992) in a mouse experiment if the diameter of 
the liposome was greater than 200 nm, liposomes’ uptake by the spleen increased and 
consequently the concentration of liposomes in the blood stream decreased quickly.  
They also showed if the diameter of liposomes was too small (less than 70 nm), 70% of 
the injected liposomes were taken up by the liver of a mouse. They concluded that 
optimal circulation activity of liposomes which correlated well with a relatively high 
uptake of liposomes by EMT6 tumor in a mouse could be reached when the diameter of 
liposomes was in a range between 70 to 200 nm. Another research group also showed 
intermediate sized liposomes (diameter, d ≈ 150-200 nm) circulated in the blood stream 
longest when three characteristic sizes (d>300 nm, d ≈ 150-200 nm, and d<70 nm) of 
liposomes were injected into mice (Litzinger 1994); the large and small liposomes were 
easily accumulated in spleens and livers of mice.  
It was also demonstrated that liposomes incorporated of lipids with a 
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covalently-linked PEG moiety increased their membrane permeability and became more 
sensitive to ultrasound excitations. The leakage and uptake process for the 
PEG-containing liposomes with mean diameters about 100 nm could be enhanced up to a 
10-fold subjected to a 20 kHz ultrasound (2 W/cm2) (Lin et al. 2003). But whether this 
enhancement resulted from the membrane destabilization, generation of pores on the 
membranes, or both by ultrasound was not known at that time. Moreover, low-frequency 
ultrasound (20 kHz) is not attractive for clinical applications because it is difficult to be 
focused to a small target. To the best of our knowledge it has no literature reporting the 
use of mega-hertz ultrasound to trigger the release of encapsulated content from 
liposomes with a diameter less than 300 nm.    
Motivated by those considerations, we have explored the responsiveness of 
PEG-containing nanometer-sized (diameter<300nm) liposomes to mega-hertz therapeutic 
ultrasound generated by a single HIFU transducer in the work presented in chapter 3. Our 
research procedure was to load fluorescent agent (FITC) into liposomes and the 
FITC-encapsulated liposomes solution was irradiated by HIFU ultrasound. To shed some 
light on the possible physical mechanisms of the content release, we analyzed the FITC 
release kinetics, the liposome size distribution change and physical integrity of the 
irradiated liposomes using a fluorescent microscopy, dynamic light scattering (DLS) and 
transmission electron microscopy (TEM). 
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1.3 Dust removal from a surface by acoustic technique 
1.3.1 Background of NASA dust mitigation project 
Exploration and habitation of the moon and Mars have become a long-term project 
for NASA (Calle et al. 2008). The presence of fine particles in Martian and lunar soil 
poses a significant threat to the success of the project. Since there is no water or other 
liquids in either environment, the mundane operation of washing away the fine 
particulates from any surface becomes impractical. The majority of particulates existing 
on the moon and Mars are silicon dioxides (SiO2).   The particle-size range is broad; it 
can be as large as sub-millimeter and as small as 10 nm (Greeley et al. 1991; Hecht et al. 
1999; Marshall et al. 1999). It has been reported that transient dust clouds exists above 
the lunar surface even the atmosphere (mixture of H, He, Ar, Na and K) pressure is very 
low on the moon surface (Stern 1999).  It was suggested that the possible physical 
principle may be as follows: The dust particles on the moon may be electrically charged 
by charged particles from the solar wind as well as UV radiation (Horanyi 1998). 
Consequently, levitation and migration of dust particles may take place near lunar surface. 
The solar panels brought to the moon during exploration by the astronauts, from which 
the electricity would be generated, may be quickly covered by dust particles making the 
electrical equipment nonoperational. Dust particles can also carry bacterial spores (Lin et 
al. 2007), as well as organic chemicals, which if transmitted out of the habitation can 
contaminate the surrounding lunar or Martian environment (Horneck 2003). Furthermore, 
the fact that dust can penetrate through seals on space suits, hatches and vehicle wheels, 
etc. may also become troublesome (Ferguson 1998; Galer 2007; Marshall 1999a; 
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Marshall 1999b). The lunar and Martian particles are also hazardous to health by causing 
respiratory disease if they are inhaled (Schrunk et al. 1999); removal of dust particles 
from these surfaces should be important. 
Development of robust dust mitigation technology is important for the viable 
long-term exploration and habitation of either the moon or Mars. Such technology should 
be effective for dislodging particles of diameter ranging from 0.01-100 μm from a surface 
of a solar panel or space suits, etc. Existing dust mitigation technology, such as 
electrostatic precipitators and mechanical filters, either use large concentration of ions or 
require frequent filter changes or manual cleaning. Moreover, such technologies are 
designed more for cleaning a flowing gas stream, rather than for the problem of dust 
mitigation from a surface, such as a solar panel, spacesuit, hatch, heat exchanger tube, etc. 
Thus, a technique to effectively remove fine dust particles from the surface in such a way 
that utilizes minimal energy and manpower as well as minimizes the surface abrasion 
involved in many manual cleaning processes is urgently needed. 
1.3.2 Acoustic levitation and its application in dust removal from a surface  
Sound is a disturbance or vibration that moves through a medium (air, liquids or 
solids) in the form of waves. The source of sound is any object that moves or rapidly 
changes shape which causes the medium around the object to vibrate. Acoustic levitation 
is a technique using acoustic standing waves that counteracts the pull of gravity and 
makes an object float in a medium.  
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Figure 1. 14. Schematic of Acoustic levitation. Small objects are pushed to the velocity antinode 
by acoustic pressure. 
 
Figure 1. 15. Typical acoustic effect of a standing wave on a suspension consisting of small Pyrex 
glass spheres with diameter 100 micron in water. 
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An acoustic levitator has two parts - a transducer or sound source and a reflector 
which bounces the sound wave back. As shown in Figure 1.14, a one-dimensional 
incident traveling plane-wave with frequency f and wavelength λ propagating along x 
direction can be represented by 0( , ) cos( )u x t u kx tω= − , where k = 2π/λ, ω =2πf, u(x, t) 
and u0 are instantaneous particle velocity and particle velocity amplitude respectively. 
Now when we place a perfect plane reflector at x = L, perpendicular to the wave 
propagation direction and ignore the attenuation, letting the incident wave be superposed 
on another traveling wave traveling in the “-x” direction (reflected 
plane-wave), 0 cos( ),u kx tω+ we obtain a standing wave given by tkxuu ωcoscos2 0= . 
The boundary condition at the reflector (assuming the reflector is rigid) 
requires: 1( )
2
kL n π= + , i. e. ( 1 2) 2L n λ= + .  Particle velocity antinodes (maxima) or 
pressure nodes are found when coskx = ± 1, x = 0, λ/2,λ, 3λ/2, ….  Likewise, pressure 
antinodes (maxima) or velocity nodes are found where coskx = 0 at positions x 
= λ/4, 3λ/4, 5λ/4…. One of the acoustic pressure antinodes should locate at 
(2 1) ,
4
nx L λ += = where n are integers.  The spacing between nearest pressure nodes or 
pressure antinodes is λ/2 (wavelength/2).  In the standing wave field, the small particles 
or small objects will be levitated and driven to acoustic pressure nodes or velocity 
antinodes by acoustic radiation force. Then the particles trapped within the planes 
migrate closer together due to the interparticle forces, whereby coagulation and even 
coalescence may be triggered. 
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 Figure 1.15 shows the typical acoustic effect of a standing wave (670 kHz) on a 
suspension consisting of small Pyrex glass spheres with diameter 100 micron in water. At 
the beginning of irradiation, almost instantaneously the spheres are driven towards the 
acoustic pressure nodes and form a series of bright clusters, whereby the average distance 
between the particles considerably diminishes. The phenomenon is applicable to all kinds 
of dispersions. The particles can be gaseous, liquid, solid, or even biological cells. The 
dispersion fluid can be gaseous or liquid.  
The application of acoustic levitation method may provide a feasible surface 
cleaning technique that would significantly reduce astronaut labor, as well as avoid the 
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Abstract 
A method to prepare liposomes is presented. Liposomes made in our laboratory were 
characterized acoustically and optically. The phase velocity and attenuation of liposomes 
in suspension (concentration = 109/mL) were measured ranging from 2 to 14 MHz using 
ultrasound spectroscopy. Anti rabbit IgG conjugated with Alexafluor 647 was delivered 
into Jurkat cells in suspension using the liposomes, by 10 % duty cycle ultrasound 
tonebursts of 2.2 MHz (the in situ spatial average temporal average = 80W/cm2) with an 
efficiency of 13 %. It has been experimentally shown that liposomes may be an 
alternative stable agent to Optison® for delivering macromolecules into cells. 
 




Liposomes or lipid vesicles are spherical structures composed of curved closed lipid 
bilayers that encapsulate liquid or gas. Their size ranges from nanometers to microns and 
the thickness of the membrane is in the order of nanometers. The most obvious features 
of the liposome that make it attractive to medicine (pharmacology in particular) include 
its ability to dissolve, protect and carry hydrophilic or hydrophobic molecules, its 
biocompatibility with cell membranes, its low antigenicity, its nanometer size allowing it 
entering organs such as the lung, spleen and liver through circulation and the relative ease 
of adding special ligands to their surface. Current research on the possible uses of 
liposomes in medicine include therapeutic (Torchilin 1985; Gabizon 1995; Gupta et al. 
2005) as well as diagnostic (Alkan-Onyuksel et al. 1996; Huang et al. 2001; Huang et al. 
2002) applications. 
Optison® (GE Healthcare, Princeton, NJ, USA), an FDA approved ultrasound 
imaging contrast agent, contains micron-size denatured albumin microspheres filled with 
octafluoropropane (an inert gas). The microbubble concentration is 5 to 8×108/mL and 
the mean measured radius of the microbubbles is 1 to 2.25 μm, according to the 
specification provided by the manufacturer. Optison® spheres have been successfully 
used in therapeutic applications in addition to be a contrast agent. It has been 
demonstrated (Bao et al. 1997; Greenleaf et al. 1998; Miller et al. 1999; Ward et al. 1999; 
Lawrie et al. 2000; Ward et al. 2000; Wu 2002; Lu et al. 2003; Miller et al. 2003) that 
ultrasound assisted by encapsulated microbubbles (EMB) such as Optison® can 
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transiently enhance the permeability of the cell membranes and deliver macromolecules 
including DNA into cells. This process is primarily caused by acoustic cavitation of EMB, 
a mainly mechanical process, and can be non-lethal to cells; this ultrasound technique is 
now called “sonoporation”. Recent studies have also shown (Wu 2005) that sonoporation 
assisted by  Optison®can also be used as a method to deliver antibodies and drugs into 
cells. 
One shortcoming of Optison® is its fragility behavior under exposure of 1-2 MHz 
ultrasound (Wu et al. 1998) of a modest intensity. Optison® micro-spheres can be easily 
broken under exposure to ultrasound whose amplitude is as low as few hundred 
kilo-pascals (Miller et al. 1999).   
It has been reported that liposomes can be stable over periods of days to weeks 
(Lasic 1993). Furthermore, liposomes that encapsulate non-gaseous materials often do 
not respond to megahertz ultrasound as vigorously as Optison®; they should be much 
more stable under ultrasound exposure of therapeutic intensity (Coussios et al., 2004).   
Our long-term goal is to use liposomes to enclose macromolecules such as drugs, DNA or 
antibodies and, under the irradiation of ultrasound, enhancing cell membrane 
permeability transiently allowing liposomes to enter cells. Under chemical stimuli, the 
macromolecules can be released from liposomes through channels existing in the vesicle 
membranes to achieve targeting drug delivery into cells (Langer 1998) .  
Nowadays, various methods for the preparation of liposomes are available; they 
were reviewed in a technical book written by Lasic (Lasic 1993). The liposomes applied 
for this research were prepared via a cast-film method using the lipids 
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Phosphatidylcholine (PC), stearylamine(SA), cholesterol (CH) mixed in the mole percent 
ratio of 65:5:30. This method was originally developed by Gupta et al. (2005). We have 
modified the molar percent ratio in preparation to maximize the effect sought by us.   
In this paper, we will introduce a method of liposome production and the way our 
liposome products were characterized acoustically using the ultrasonic spectroscopy  
(Wu 1996) and acoustic imaging. We will also briefly mention how Liposome size 
distribution was determined optically using a dynamic light scattering method. Lastly, we 
will report how liposomes were used to deliver antibodies into Jurkat cells, and compare 
its delivery efficiency with that of Optison®. Our results are preliminary and further 
improvement is needed. 
MATERIALS AND METHODS 
I. Liposome and its Charactrization 
1. Preparation of Liposomes 
Phosphatidylcholine (PC), stearylamine(SA), and cholesterol (CH) were purchased 
from Sigma Chemicals (Sigma Chemical Co., St. Luis MO). Routine reagents and solvent 
were of analytical grade. 
Component lipids of PC, SA and CH, totaling 350mg, were mixed in the mole 
percent ratio of 65:5:30 and dissolved in 10ml of chloroform in a round-bottomed flask. 
The chloroform solvent was removed by evaporation under reduced pressure using a 
rotary vacuum evaporator (Buchi Rotavapor R-200, BÜCHI Labortechnik AG 
Meierseggstrasse 40 Postfach CH-9230 Flawil 1 Switzerland). Lipid film was hydrated 
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with 35 ml deionized water to yield a concentration of 10 mg lipid/ mL by continuous 
votex-mixing of the flask. The rehydrated mixture in a plastic culture tube of 10 mm 
diameter and 75 mm length (Kimble, Owens-Illinois, Toledo, OH) was sonicated with 20 
kHz ultrasound for 2 minutes with a power of 12W (reading from the system) using the 
microprobe of a sonicator (Misonix Sonicator 3000, Misonix, Inc. New Highway 
Farmingdale, NY, USA). 
2. Sample holder and Sample Preparation 
Liposomes or Optison® in phosphate buffered saline (PBS) with a concentration of 
about 109/mL and 4.5×107/mL respectively was introduced into a metallic cylindrical 
sample-holder with a wall thickness of 3 mm and a diameter of 58 mm. The cylinder uses 
two latex membrane (60 μm) acoustic windows (32 mm diameter) centrally located at 
both ends of the sample holder (Fig. 1). The membranes were also used to seal the sample 
from leakage. Dimensions of the container that can be used to hold sample are 32 mm×7 
mm (diameter x width).    
3. Liposome Sample Characterization using Ultrasonic Spectroscopy and the light 
scattering 
Ultrasonic spectroscopy was described in detail elsewhere (Wu 1996). It provides a 
means of determining both attenuation and phase velocity simultaneously over a broad 
range of frequency. In brief, a temporally narrow ultrasonic pulse generated by a 
broadband polyvinylidene fluoride (PVDF) transducer (Ultrasonic Limited, Fleet, 
Hapshire, England, GU13, 9RL) driven by a pulser/reciver (Model PR 5000, Matec 
Instrument, Northborough, MA, USA), in a water tank is received by another similar 
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PVDF transducer, amplified and digitized using a digital HP 5810 A oscilloscope; then, 
the sample/sample holder is inserted between them and the waveform transmitted through 
the specimen is also digitized (Fig. 1). A complex spectrum of Fourier Transform is 
obtained from the waveform with the sample inserted divided by that without the sample 
inserted to calculate the attenuation and velocity of the sample. Data are corrected for 
acoustic impedance discontinuities at both membrane of the sample holder and water 
interfaces. The detail will be discussed in a section below. 
  
Fig. 1. Illustration and blockdiagram of ultrasound spectroscopy technique used to measure the 
phase velocity and attenuation of the liposome solution. The measurement was performed 
immediately after the sample was stirred.  The water tank was filled with distilled water and 
temperature was measured to be 22 °C. 
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Liposomes size distribution was determined by the autocorrelation function 
determined by the dynamic light scattering method (Bruce et al. 2000) using a 
commercial system (BI-200SM goniometer, Brookhaven Instruments Co. Holtsville, NY, 
USA). 
4. Evaluation of the stability of Lipsomes  
The stabilities of Liposomes and Optison® under exposure of ultrasound were tested 
by using a portable ultrasonic imaging system (4V2, 5 MHz Array, Model 2000, Terason, 
Burlington, MA, USA). Liposomes or Optison® suspension was prepared as described 
above with a concentration 109/mL and 4.5×107/mL respectively. Prepared suspension 
then was poured into the cylindrical sample-holders that were described in section I, 2.  
An ultrasound absorbing disk (SOAB, a product was manufactured a long time ago, the 
manufacturer is unknown) was glued to the back of the sample holder to minimize 
reflection of the tank wall. The sample holder was placed in the water tank as shown in 
Fig. 2. Ultrasonic images were captured using the Terason 2000 imaging system. An 
off-line pixel gray scale analysis of the sample image was then performed.  
The same sample/sample holder was taken out of the water tank and exposed to 
ultrasound (US) for 20 s (exposure parameters will be described in section II, 3).  
Immediately after US exposure, the sample/sample holder was placed in the water tank 
again. Ultrasonic images were captured using the Terason 2000 imaging system and an 




Fig 2.  Terason 2000 ultrasound imaging system was used to study the stability of the liposome 
solution. The measurement was performed immediately after the sample was stirred.  The 
water tank was filled with distilled water and temperature was measured to be 22 °C. 
 
II. Sonoporation Assisted by Liposomes  
1. Cell Preparation 
Jurkat lymphocytes, human T-lymphocyte cells, widely used in biological research, 
were incubated in a humidified 37o C, 5% CO2 atmosphere inside 75 cm2 tissue culture 
flasks (Corning Incorporated, Corning, NY, USA) within a solution of RPMI (Medium 
1640, liquid tissue culture medium containing a nutrient blend of amino acids, vitamins, 
carbohydrates, organic and inorganic supplements and salts) (GIBCO BRL, Grand Island, 
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NY, USA) supplemented with 5% fetal bovine serum (FBS).  
2. Ultrasound Exposure Preparation 
Antibodies or immunoglobulins (Ig) are a group of glycoproteins present in the 
blood serum and tissue fluids of mammals. One type of antibodies is IgG; most 
antibodies in serum are in the IgG class. Here we used anti rabbit IgG. Each sample 
consisted of 1ml of Jurkat cell suspension supplemented with10μL anti rabbit IgG 
conjugated with Alexafluor 647 (Molecular Probes, Eugene, Oregon, USA) of a 2mg/mL 
concentration. Alexafluor 647, a fluorophore, was used as a marker for detection. The 
molecular weight of IgG is about 150,000 Da. Normally, it is not possible to introduce 
IgG into cells non-invasively. When fluorescent Jurkat cells were detected by a flow 
cytometer (see section II. 4 for detail), IgG conjugated with Alexafluor 647 was delivered 
into the cells. 
Each sample was placed in a 12×75mm culture tube (VWR Scientific, West Chester, 
PA, USA) for ultrasound exposure or sham exposure with addition of either 1) Optison® 
or 2) liposomes. Optison®'s initial bubble concentration obtained from the commercial 
vial was 5.0 to 8.0×108/mL according to the specification of the manufacturer. The final 
bubble concentration was 4.5×107/mL. The initial concentration of liposomes was about 
1010 (Coussios et al. 2004) and the final value was 109/mL. 
3. Ultrasound calibration and application 
The ultrasonic system used was described elsewhere (Pepe et al. 2004). The 
transducer used was a 2.5 cm diameter planar non-focusing transducer (Model: A 304 S, 
Panametrics, Waltham, MA, USA), driven by a Hewlett Packard 3314A function 
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generator (Hewlett Packard, Palo Alto, CA, USA) and an ENI 3200L RF power amplifier 
(ENI, Rochester, NY, USA) as shown in Fig. 3. The measured -6dB beam-width at situ 
was 2.5 cm. The center frequency was 2.2 MHz. The transducer was driven intermittently 
with a 10% duty cycle (on cycles/off cycles = 20/180, pulse repetition frequency = 10 
kHz). The test tube was situated at 1 cm distance from the source transducer; the -6 dB 
beam-width is about 2.5 cm, much greater than the test tube diameter. 
 
 
Fig. 3. Ultrasound exposure setup for sonoporation experiments. The transducer used was a 2.5 
cm diameter planar non-focusing transducer (Model: A 304 S, Panametrics, MA, USA). Acoustic 
parameters used are: 2.2 MHz, 10 % duty cycle, ISATA = 80 W/cm2.  The water was filled with 
distilled water and temperature was measured to be 22 °C. 
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Each tube sample was rotated at 200 rpm by a DC motor throughout the exposure 
period; the rotation helps to mix cells with Optison® bubbles (liposomes) evenly. The test 
tube sample was lowered into a glass tank filled with distilled water and aligned axially 
with the ultrasound transducer. The Optison® spheres and cell suspension (hereafter it is 
called Optison® sample) or the liposomes and cell suspension (hereafter it is called 
liposome sample) were mixed and then immediately exposed to ultrasound (US). The 
control samples (liposomes + antibody + cells) were sham-exposed to US. 
The in situ spatial average temporal average (SATA) intensity for each case after 
attenuation correction was 80W/cm2 and the value of fp /− , a quantity related to the 
mechanical index  MI (NCRP, 2002 ), was calculated to be 1.1, where p- in MPa and f in 
MHz are the rarefaction amplitude and frequency of ultrasound respectively.  These 
parameters were measured by a needle pvdf (0.2 mm diameter) hydrophone (NTR 
Systems, Seattle, Washington, USA) that was calibrated by measuring the acoustic 
radiation force generated by the transducer using an electronic balance and scanning a 
two-dimensional sound field in situ. The attenuation of the test tube was found by 
measuring the short ultrasound pulse amplitude with/without placing the test tube before 
the hydrophone (note that the ultrasound was attenuated twice using this method and the 
standing wave effect is small as the reflection coefficient of acoustic pressure of the test 
tube was measured to be less than 0.1). Since the sample tube was placed in the near field, 
the nonlinear distortion of the waveform was not serious, and the peak positive and peak 
negative pressures were found to be equal. 
Each sample was exposed to US in the following way: Samples with 100 μL of 
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either 1) Optison® or 2) liposomes added were exposed to ultrasound for 10 seconds. 
Three trials were performed in the same fashion for each of the three cases: 
liposome sample sham-exposed, liposome sample ultrasound exposed and Optison® 
sample ultrasound exposed. A t-test statistical model (two-sample assuming unequal 
variances) provided by a soft ware package SigmaStat® (SPSS Inc. Chicago, USA) was 
used to compare the delivery efficiency between liposome sample, sham-exposed and 
liposome sample US exposed and between liposome sample, sham-exposed and Optison® 
sample US exposed.   
4. Evaluation of transfected cells - Flow Cytometer 
Immediately after sonoporation experiments, the cells were washed twice, 
resuspended in 1 ml PBS and tested for viability and fluorescence (it is an indication of 
successful delivery) by using a flow cytometer (Coulter EPICS ELITE ESP, Beckman 
Coulter International, Inc., Miami, FL, USA) housed in the University Medical College.   
RESULTS AND DISCUSSION 
Figure 4 is a histogram of relative scattered light intensity vs liposome diameter.  
This figure suggests the diameters of liposomes were clustered into three different scale 
groups. The mean diameter was determined to be 110 nm by the light scattering method. 
According to the scattering R4 law, where R is the radius of a sphere (Marion et al. 1980), 
the large diameter liposome should scatter much more light than a small one. Thus, in 
terms of number density (numbers/volume), actually, number of small diameter 
liposomes (~ 50 nm) should dominate. 
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Fig. 4. Relative scattered light intensity histogram of the liposome sample 
 
 
The phase velocity vs frequency and attenuation vs frequency for the liposome in 
PBS solution of the number concentration 109 are shown in fig. 5. It is clear the 
attenuation of liposome sample is two orders of magnitude smaller than that of  
Optison® of 107/mL concentration (the attenuation of the Optison®sample can be higher 
than 100 dB/cm) at 5 MHz (Marsh et al. 1997; Wu 1998) . The phase velocity did not 
change significantly with the frequency and it was very close to that of blood (Duck 
1990). 
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Fig. 5. Phase velocity and attenuation of the liposome sample. Solid lines are for phase velocity 
and dotted lines are for attenuation. 
 
The first row of figure 6a contains 2 images of the Optison® sample/sample holder 
(from left to right) captured before sonification and after sonification (2.2 MHz and the in 
situ spatial average temporal average was 80W/cm2, the detailed sonication parameter 
was described in section II, 3) by the Terason 2000 imaging system using a 4V2 (5 MHz) 
array. The image on the left panel shows a bright white-band located by the top arrow on 
the left in the figure. The similar but slightly less thick white-band occurred when 
Optison® spheres were replaced by pure water (not shown); it suggests that the 
white-band illustrated by the top arrow was generated by the front latex membrane 
window and Optison® spheres just under the membrane. Since attenuation of the 
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Optison® spheres of 107/mL concentration can be higher than 100 dB/cm at 5 MHz 
(Marsh et al. 1997; Wu 1998), a strong shadowing effect has made Optison® spheres 
under the band, the back latex window of the container and the front SOAB surface, 
invisible as pointed by the bottom arrow on the left. On the other hand, the back window 
and the SOAB surface were visible from the right panel after 20 s ultrasound exposure. 
The 20 s ultrasound exposure made many Optison® spheres rupture and disappear and 
ultrasound could now reach as far as the front SOAB surface.  
The two panels of the second row are enlarged images of the portions (between two 
arrows) of images of the top row respectively. The two bar figures of the third row show 
the gray scale histograms of the images of the second row. Each image shown in the 
second row was spatially uniformly divided into 8 sub-bands; each sub-band had 10 
(row)×187 (column) pixels. The gray scale of each pixel was presented in a 8 bit integer.  
The gray scale of a sub-band shown in a bar figure of the third row was the sum of the 
gray scale of all pixels in the sub-band. The gray scales of the first three sub-bands of the 
left image were higher than those corresponding sub-bands of the right image. On the 
contrary, the gray scales of the last five sub-bands for the right image were higher. These 





Fig. 6. (a) Stability test results obtained for the Optison®sample. (b) Stability test results 




Fig. 6. Conitinued. 
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Figure 6b is a similar plot when the sample holder was filled with liposomes of 
109/mL concentration. The first row has three images; they were captured by the same 
ultrasound system before, after 20 s and 40 s ultrasound exposure respectively. The 
common feature of these three images is that they all have three bright white bands.  
They were generated by the front, back acoustic windows and the front surface of the 
SOAB. Since the attenuation of liposomes at megahertz frequencies was rather low as 
shown in fig. 5, there was no shadowing effect observed. The three panels of the second 
row are enlarged images of the portions (between two arrows) of images of the top row 
respectively. The three bar figures of the third row show the gray scale histograms of the 
images of the second row. The first two sub-bands’ gray scales of the middle panel 
decreased slightly from the left panel’s. The other sub-bands’ gray scales were essentially 
unchanged. Those bar figures indicate that liposomes were quite stable under the 
sonification. 
Figure 7 is a plot that shows the results of the antibody delivery experiment.  Cell 
viability and fluorescence (it is an indication of successful delivery) for the controls 
(Sham exposure), Optison® samples and liposome samples detected by a flow cytometer 
are presented here. Each datum is presented as a mean of three trials of three samples 
prepared the same way ± standard deviation. The cell viabilities were 93.3 % ± 0.7 %, 
89.2 % ± 4.8 %, 88.4 % ± 1.1% for the control, liposome sample and Optison® sample 
respectively. The antibody delivery efficiencies were 1.4 % ± 0.2 %, 13.1 % ± 2.6 %, and 
35.1 % ± 0.4 % for the liposome sample sham-exposed, liposome sample and Optison®  
sample respectively. The delivery efficiencies of Optison® (p < 3×10-7) and liposome (p 
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< 0.008) were significantly higher than that of the sham-exposed when they were 
individually compared with the data of sham-exposed using the t-test statistical model.  
The cell viabilities were very close to each other for all three cases (sham-exposed, 
liposome and Optison®). 
  
 
Fig. 7. Sonoporation result comparion when Optison® and liposome were used. 
 
Our above preliminary experimental results have shown that liposomes like 
Optison® have assisted ultrasound to deliver antibodies into Jurkart cells. Although the 
delivery efficiency of our current technique is lower than that when Optison® was used, 
the improvement of liposome preparation method and optimizing acoustic parameters 




Fig. 8. Illustartion of a passive cavitation detector. The transducer (Model: A 304 S, Panametrics, 
MA, USA) was mounted in such a way to make sure that ultrasound transmitted by the 
transducer would reach the sample but not be received directly by the needle hydrophone. The 
hydrophone could only receive the scattered signal from Optison®spheres or liposomes. The 
acoustic parameters used were the same as those shown in Fig. 3. 
 
In order to understand the physical mechanism of this technique that uses liposomes, 
a passive acoustic cavitation detector (Roy et al. 1990) as shown in fig. 8 was set up to 
detect if cavitation was involved. The ultrasound transducer and acoustic parameters used 
in fig. 3 were also used as the source transducer and the parameters in this experiment. 
The sample holder in fig. 8 was mounted horizontally instead of vertically. The reason for 
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doing that was since Optison® sphere usually floated to the top, thus, a needle pvdf (0.2 
mm diameter) hydrophone (NTR Systems, Seattle, Washington, USA) used to detect the 
scattering signal could be mounted very close to Optison® sphere or liposomes. Thus, the 
hydrophone with a 30 dB amplifier was sensitive enough to detect the sub-harmonics 
component (according to the calibration of the hydrophone manufacturer, the sensitivity 
of the hydrophone at 1 MHz is similar to that of 2 MHz), a signature of acoustic 
cavitation (Leighton 1994). The transducer was mounted in such a way to make sure that 
ultrasound transmitted by the transducer would reach the sample but not be received 
directly by the needle hydrophone. Ultrasound reflected by the latex membrane window 
could not reach the hydrophone either. The hydrophone could only receive the scattered 
signal from Optison®spheres or liposomes. As expected, when the sample holder was 
filled with distilled water, no meaningful signal except noise was received by the 
hydrophone. The signal received by the hydrophone when the sample holder was filled 
with Optison®sample or liposome sample had fundamental (2.2 MHz) and sub-harmonic 
(1.1 MHz) components among other harmonic components. For the fundamental, they 
were 12 dB and 10 dB above the noise amplitude for Optison®sample and liposome 
sample respectively. For the sub-harmonic, they were 6 dB and 4 dB above the noise 
amplitude for Optison®sample and liposome sample respectively. These results seem to 
suggest acoustic cavitation did occur during sonoporation process with the presence of 
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CHAPTER 3   
 
AN IN VITRO FEASIBILITY STUDY OF CONTROLLED DRUG 
REALEASE FROM ENCAPSULATED NANOMETER 
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Abstract 
A liposome with a diameter ranging from 150 to 200 nm has been considered to be one of 
the optimal vehicles for targeting drug delivery in vivo since it is able to encapsulate drug 
and also circulate in the blood stream stably. Its small size, however, makes controlled 
release of its encapsulated content difficult. A feasibility study for applications of high 
intensity focused ultrasound (HIFU) of the mega-hertz frequency to induce controlled 
release of its content was carried out. This study, using the dynamic light scattering and 
transmission electron microscopic observation, demonstrated 21.2% of encapsulated 
fluorescent materials (FITC) could be released from liposomes with an average diameter 
of 210 nm when exposed to continuous (cw) ultrasound at 1.1 MHz ( ISPTA= 900 W/cm2) 
for 10 s and the percentage release efficiency can reach to 70% after 60s’ irradiation. This 
result also reveals that rupture of relatively large liposomes (>100nm) and generation of 
pore-like defects in the membrane of small liposomes (<100nm) due to HIFU excitation 
might be the main causes of the release; the inertial cavitation took place during the 
irradiation. The controlled drug release from liposomes by HIFU may be proven to be a 
potential useful modality for clinical applications. 
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1. Introduction 
Since their discovery [1], liposomes have been explored to be carriers for potential 
applications in targeting and controlled drug delivery in vivo. Liposomes (or lipid vesicles) 
that encapsulate liquid or gas usually have spherical structures and are composed of 
curved and closed lipid bilayers. Their size ranges from 50 nm to several micrometers.  
The attractive features of the liposome for medical applications are: (1) ability to protect 
and carry hydrophilic or hydrophobic molecules encapsulated inside; (2) biocompatibility 
of their bilayers with cell membranes; (3) relatively low antigenicity; (4) nanometer small 
size allowing them to circulate in the blood stream stably, and (5) the relative ease of 
adding special ligands to their surface. Drug, DNA or other therapeutic agents can be 
either bound to the lipid or entrapped in the aqueous core of liposomes [2-4]. In general, a 
drug-loaded liposome remains stable and inactive physiologically until the physical 
integrity of the lipid membrane is disturbed. A desirable liposome drug delivery 
procedure should be as follows: First, liposomes are loaded with drug and circulate in the 
blood.  The encapsulated drug is then released at a controlled rate upon an appropriate 
stimulus. Chemical and physical methods including pH value, temperature, electric fields, 
and ultrasound [5-8] for triggering drug release from liposomes have been explored. 
Among them, ultrasound (US) has a unique advantage as a localized stimulus tool since it 
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can propagate into deep tissue and also can be focused specifically into the target [9].  
Our previous study demonstrated that when exposed to 2.2 MHz 10% duty cycle pulsed 
US (in situ spatial average temporal average intensity, ISATA = 80W/cm2), liposomes 
served as cavitation nuclei were able to promote acoustic cavitation during sonoporation 
process [10]; cavitation in turn enhanced the drug uptake by the cells. A study by 
Kopechek et al. [11] showed that 6-MHz ultrasound (continuous wave, 2-7 W/cm2) could 
induce leakage from liposomes of mean diameter 780 nm. The percentage of calcein, the 
fluorescence marker encapsulated in the liposomes, released from liposomes reached 
47.5% ± 33%. A similar release of 32% from liposomes of mean diameter 800 nm of 
encapsulated calcein was achieve by Huang and Macdonald [8] by excitation of 10s 
continuous wave ultrasound at 1 MHz and 2 W/ cm2.  
To enhance the drug delivery efficiency, the size of liposomes plays a crucial role. It 
was demonstrated by Liu et al. [12] in a mouse experiment if the diameter of the 
liposome was greater than 200 nm, liposomes’ uptake by the spleen increased and 
consequently the concentration of liposomes in the blood stream decreased quickly.  
They also showed if the diameter of liposomes was too small (less than 70 nm), 70% of 
the injected liposomes were taken up by the liver of a mouse. They concluded that 
optimal circulation activity of liposomes which correlated well with a relatively high 
uptake of liposomes by EMT6 tumor in a mouse could be reached when the diameter of 
liposomes was in a range between 70 to 200 nm. Another research group also showed 
intermediate sized liposomes (diameter, d ≈ 150-200 nm) circulated in the blood stream 
longest when three characteristic sizes (d>300 nm, d ≈ 150-200 nm, and d<70 nm) of 
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liposomes were injected into mice[13]; the large and small liposomes were easily 
accumulated in spleens and livers of mice.  
It was also demonstrated that liposomes incorporated of lipids with a 
covalently-linked poly (ethylene glycol) (PEG) moiety increased their membrane 
permeability and became more sensitive to US excitations. The leakage and uptake 
process for the PEG-containing liposomes with mean diameters about 100 nm could be 
enhanced up to a 10-fold subjected to a 20 kHz ultrasound (2 W/cm2 ) [14]. But whether 
this enhancement resulted from the membrane destabilization, generation of pores on the 
membranes, or both by US was not known at that time. Moreover, low-frequency 
ultrasound (20 kHz) is not attractive for clinical applications because it is difficult to be 
focused to a small target. To the best of our knowledge it has no literature reporting the 
use of mega-hertz US to trigger the release of encapsulated content from liposomes with 
a diameter less than 300 nm.    
Motivated by those considerations, we have explored the responsiveness of 
PEG-containing nanometer-sized (diameter<300nm) liposomes to mega-hertz therapeutic 
ultrasound generated by a single HIFU transducer. Our research procedure was to load 
fluorescent agent (FITC) into liposomes first. Then liposome solution was irradiated by 
HIFU ultrasound. To shed some light on the possible physical mechanisms of the content 
release, we analyzed the FITC release kinetics, the liposome size distribution change and 
physical integrity of the irradiated liposomes using a fluorescent microscopy, dynamic 
light scattering (DLS) and transmission electron microscopy (TEM). 
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2. Materials and methods 
2.1 Liposome syntheses 
1, 2-Diacyl-sn-glycero-3 phosphocholine (PC) (Sigma-Aldrich, St. Louis, MO, USA) 
and 1,2-Dipalmitoyl-sn-Glycero-3-Phosphoethanolamine-N-[Methoxy (Polyethylene 
glycol)-2000] (PEG2000-DPPE) (Avanti Polar Lipidsm, Inc., Alabaster, AL, USA) were 
mixed to the mole percent ratio of 95:5 and dissolved in chloroform in a round-bottomed 
flask. The chloroform solvent was removed under N2 using a rotary evaporator to 
generate a lipid film attached to the inner flash wall. Amount of 0.1 mg/mL FITC solution 
was made by dissolving the FITC powder (Sigma-Aldrich, St. Louis, MO, USA) in 
phosphate buffered saline (PBS) solution (pH 7.4). Appropriate amount of FITC solution 
(0.1 mg/mL) was added to the flask to rehydrate the lipid film to a concentration of 5 mg 
lipid/mL by continuous vortex-mixing of the flask for 3 hours in a 70ºC water bath. A 
milky solution of liposome was obtained subsequently. Some of the FITC solution was 
encapsulated inside the liposomes during the swelling of the lipid film. The liposome 
solution was distributed to plastic culture tubes (12×75mm, VWR, West Chester, PA, 
USA) by 1mL in each. The fluorescent light coming out from the test tube was too strong 
to be detected optically when the sample was observed by using a fluorescent microscope. 
To avoid saturation, we needed to reduce the fluorescent light intensity from the solution. 
The sample in the test tube was diluted two times. For each dilution, the sample solution 
was first made uniformly distributed in a test tube by a vortexer (model: G-560, VWR, 
West Chester, PA, USA). Then we replaced the top half solution in each tube by 0.5 mL 
PBS. After two dilutions, the fluorescent light intensity reduced to about ¼ of the initial 
 68
value.  The concentration of liposomes in the diluted solution in the test tube did not 
change; it was checked out by using the dynamic light scattering method (detailed 
description will follow in later section). These samples were ready to be sonicated. The 
average fluorescein (FITC) encapsulated in the liposome was much higher than that in 
the solution, the fluorescent intensity in the solution would increase if rupture of or 
leakage from liposomes was induced under the irradiation of US.  
A group of control samples were made by the same procedures mentioned above 
except the lipid film was rehydrated by the PBS solution instead of FITC solution. A 
same amount of FITC powder was added to the solution after the liposomes had been 
formed to yield the same concentration of FITC in the solution (0.1 mg/mL). In other 
words, the liposomes in the control sample solution had no FITC solution encapsulated 
inside; the control sample was just a mixture of liposomes which encapsulated PBS and 
the FITC solution from which the other group of encapsulating FITC liposomes were 
made. The average fluorescent intensities (Fc) of the control samples (n = 4) should be 
equal to that of the encapsulating FITC liposome-solution after the 100% release of FITC 
from the liposomes.  
2.2 Ultrasonic exposure and scanning system 
The ultrasonic system was shown in Fig.1. The transducer used was a single-element 
focusing piezo-ceramic HIFU transducer (Sonic Concepts, Seattle, WA) operating at f0 
=1.1 MHz (geometric focal length d = 62 mm, active radius, a = 32 mm). The transducer 
can be moved in 3 orthogonal directions by computer-driven stepper motors (AIMS-001, 
NTR Systems, Seattle, WA) with the smallest step of 0.1 mm. The transducer and test 
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tube were mounted in a glass tank containing filtered distilled and degassed (d-d) water. 
Position of the transducer was carefully chosen in such a way that its focal point 
coincided with the center of the liposome suspension volume in the test tube. An arbitrary 
waveform function generator (33250A, Agilent, Santa Clara, CA), produces a continuous 
(cw) sinusoidal signal for various sonication durations as programmed and its output was 
applied to an input of a 55 dB Radio frequency (RF) power amplifier (ENI A300, 
Rochester, NY, USA) for amplification.  The output of the power amplifier was used to 
drive the transducer. 
To avoid the damage of the hydrophone, the transducer was first excited by a low 
voltage short electric pulse (3 cycles) with the center frequency equal to 1.1 MHz to 
generate a low acoustic signal in d-d water and the signal was measured using a needle 
pvdf broadband piezoelectric hydrophone (NP1000, NTR Systems, Seattle, WA) with an 
active sensing diameter of 0.2 mm. The hydrophone output voltage was digitized and 
displayed using a digital oscilloscope (model 54642A, Agilent, Santa Clara, CA) with a 
bandwidth of 500 MHz. The beam two-dimensional profile and the -6 dB beam-widths 
along the lateral (perpendicular to the US propagation direction) at the focal plane were 
determined to be approximately 2 mm. 
The acoustic power was measured using the radiation force measurement method 
[15, 16]. The system included a laboratory balance with the accuracy of 1 mg (Model 403, 
Denver Instrument, Denver, Co.) and an ultrasound absorber made of a material has a 
negligible reflection coefficient. The total acoustic power W is calculated by 
)])2/(cos[arctan1/(2 adcmgW += , where m is reading from the balance in kg, c (speed 
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of sound in water) = 1,500 m/s, d is the diameter of the transducer, a is the radius of the 
curvature of the transducer surface and g (gravitational acceleration) = 9.8 m/s2. The 
spatial peak pulse average intensity ISPPA in water (it is also equal to the spatial peak 
temporal average ISPTA since it was cw) was estimated by using measured acoustic power 
divided by π (d-6dB/2)2. In this study, ISPPA= ISPTA = 900 W/cm2, 1.1 MHz continuous wave 
(cw) was used.  
 
Fig. 1. Block diagram of the experimental setup. 
 
Those sample tubes, after the two dilutions described above, were exposed to US for 
10s, 20s, 30s, 40s, 50s and 60s. Ultrasound exposure was performed quickly after a 
sample was prepared. To sonicate the liposome suspension evenly, each test tube was 
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rotated at 200 rpm by a DC motor throughout the exposure period. Immediately after the 
sonication, each test tube was measured for fluorescent light intensity. The same 
measurement was done to those control sample tubes.  
2.3 Leakage measurements 
Irradiation of ultrasound induced the rupture of the liposomes and/or leakage of 
encapsulated FITC to the ambient solution. The liposome solutions after exposed to 
various sonication periods were examined by an inverted fluorescence microscopy 
(Nikon, Garden city, NY) operating at an epifluorescent mode, the wavelengths of the 
excitation and fluorescence were about 440 nm and 530 nm respectively.  The 
fluorescence 530 nm signal was captured using a photomultiplier tube (PMT) (Oriel 
70680, ORIEL, Stratford, CT) equipped with a high-gain amplifier (Oriel 70701, ORIEL, 
Stratford, CT), and recorded as F(t). The PMT was biased at 1100 V using a high-voltage 
power supply, (Oriel 70705, ORIEL, Stratford, CT). The ultrasound triggered liposome 
release was assessed as: 








− ×−    (1) 
where F0 and Fc are fluorescent light intensity readings of the FITC encapsulated 
liposome suspension before US irradiation and the control suspensions respectively.  If 
F(t) = Fc, FITC release efficiency = 100 %; complete encapsulated FITC release is 
achieved.    
2.4 Liposome Size Distribution Analysis  
Liposome size distributions before and after US irradiation and liposome 
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concentration in solution were determined by the autocorrelation function of the dynamic 
light scattering (DLS) method [17] using a commercial particle sizer (BI-200SM, 
Brookhaven Instruments Co., Holtsville, NY).  
2.5 Transmission electron microscope & the sample preparation 
To observe the effects of US irrdiation on liposome membranes, such as rupture or 
leakage, liposomes before and after the sonication were imaged by a transmission 
electron microscopy (TEM) (JEM 1210, JEOL USA, Inc., Peabody, MA). The liposome 
samples for TEM were prepared by a negative staining technique. In brief, the carbon 
coated grids were treated with 1% Alcian Blue in water to make them hydrophobic. 6 - 10 
μl of liposome samples were placed on a grid. After 1 minute, seven drops of 1 or 2 % 
aqueous uranyl acetate were washed slowly over the sample side of the grid. The final 
drop of uranyl acetate was allowed to stay on the grid for 1 minute. It was then wicked 
off with a piece of filter paper. Grids were thoroughly air-dried and examined by TEM.  
3. Results and discussion 
All data points in this study are presented by the mean and its standard deviation of 4 
measurements (mean ±  div) unless specified otherwise. The liposome solution was 
diluted to 1/100 of its original concentration by the PBS before they were examined by 
the DLS. The mean diameter of the PC-PEG 2000 liposomes was measured to be 210.4 ± 
2.4 nm using DLS. The mean diameter of the liposomes dropped to 179.2 ± 0.97 nm after 
they were exposed to the cw US for 120 s, as shown in Fig. 2. The 3 panels inserted in 
Fig. 2 are typical liposome size distributions of the samples that were sham-exposed (0 s), 
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and sonicated for 30s and 120s, respectively. Panel A suggests that the diameters of 
liposomes synthesized by our method varied in a range from 130 nm to 300 nm. However, 
all the liposomes with diameters larger than 230 nm were probably ruptured after 30s of 
sonication since there is no light intensity contributed by them as indicated in panel B. 
Panel C, compared with panel B, suggests the size of liposomes was further decreased 
after 120 s’ sonication. 
  
Fig. 2. The decreasing trend of liposome size with various duration of sonication. Panels A, B, 
and C are the typical liposome size distributions determined by the dynamic light scattering 









Fig. 3. Percentage FITC release from liposomes triggered by HIFU ultrasound (1.1 MHz, ISPTA= 
900 W/cm2, cw) vs time. 
 
 
Figure 3 shows the percentage release efficiency from the liposomes calculated 
using Eq. 1; all quantities in Eq. 1 were determined by the measurement of fluorescent 
light intensity described earlier (Eq. 1) after exposed to the US for 10s, 20s, 30s, 40s, 50s 
and 60s respectively. It can be seen that HIFU ultrasound (1.1 MHz, ISPTA= 900 W/cm2, 
cw) was able to release 21.2% ± 4.1% of encapsulated FITC from liposomes of 210 nm 
mean diameter within 10 s. The FITC release efficiency could reach as high as 70 % after 




Fig. 4. The frequency spectra of the signal captured by the 0.5 MHz plane transducer when 
sample tubes exposed to HIFU US irradiation (CW, 1.1 MHz, ISPTA= 900 W/cm2). (Top: test tube 
contained 1 ml distilled and degassed water. Bottom: test tube contained 1 ml liposome’ solution) 
 
In order to understand the physical mechanism of the release induced by HIFU 
further, a 0.5 MHz nonfocusing 1.2 cm diameter transducer as shown in Fig. 1 was used 
to detect  ½ f0 = 0.55 MHz (subharmonic) signals. The presence of the subharmonic 
frequency signal indicates acoustic cavitation may be involved [9]. The Fourier frequency 
spectra of acoustic pressure signals collected during the sonication process with the d-d 
water (top panel) and liposome solution (bottom panel) were separately shown in figure 4. 
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Both samples were exposed to cw HIFU at f0 =1.1 MHz (ISPTA= 900 W/cm2). As expected, 
when the test tube was filled with d-d water, no other signal except the fundamental f0 
was received by the 0.5 MHz transducer. There was no sub-harmonic peak (in the vicinity 
of 0.55 MHz) in the spectrum shown in the top panel. The signal received by the 0.5 
MHz plane transducer when test tube was filled with liposome solution had both 
fundamental (1.1 MHz) and sub-harmonic (0.55 MHz) components, which were 11 dB 
and 10 dB above the noise amplitude, respectively.  
The structure of liposomes before and after exposure to HIFU was examined by 
transmission electron microscopy (TEM). Figure 5 (top left and top right) represents 
some typical liposomes before exposure to HIFU. Intact liposomes had circular shape and 
most of them had uni-lamellar structures. The liposome membranes were clearly visible 
as the inner aqueous compartments were slightly darker than the surrounding perimeters. 
The size of liposomes varied from less than 100 nm to 300 nm with an average diameter 
of 210 nm measured by the DLS technique. Structures of the liposomes after irradiated 
for 30 s by US of 1.1 MHz, ISPTA =900 W/cm2 are shown in Figure 5 bottom left and right 
panels. It is evident that HIFU induced fractures in liposomes of a wide range of sizes. 
Some Large liposomes (>100 nm) were broken in half or had significant portions of 
membranes missing. Some of the small liposomes had pores or openings on their surfaces. 
The number of smaller liposomes detected by DSL increased after the irradiation. Overall 
the color contrast between the inner core and the background solution outside of 
liposomes was reduced for the sonicated liposome solution, suggesting that the FITC 
leakage was induced from irradiated liposomes, there was probably no FITC left inside 
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those liposomes though they still looked like circular in shape.   
 
Fig. 5. Transmission electron microscopy (TEM) images of liposomes before sonication (top left 
and right), liposomes after sonication (bottom left and right). US parameters: 1.1 MHz, ISPTA= 
900 W/cm2, 30 s, CW. Scale bar = 100 nm. 
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4. Conclusions 
This in vitro study demonstrated that HIFU is capable of effectively inducing 
leakage of contents from liposomes with an average diameter of 210 nm in a short period 
of irradiation. The release kinetics of the encapsulated fluorescent materials (FITC) 
suggests the content release efficiency up 70 % from liposomes in the suspension can be 
obtained after 60 s’ sonication by US of ISPTA = 900 W/cm2. The TEM images of 
liposomes revealed the strong effect of HIFU on the liposome membrane as the main 
cause of the drug release. The destructive effect of the HIFU to the nanometer size 
liposomes and the presence of a strong subharmonic spectrum shown in the bottom panel 
of Fig. 4 suggest inertial cavitation might dominate in the sonication process and 
liposomes might play a role as cavitation nuclei. Figure 5 suggests that fracture of 
relatively large liposomes (>100nm) and generation of pore-like defects in the membrane 
of small liposomes might be the predominant mechanisms of encapsulated content 
released from liposomes.  
The potential clinical applications of the targeted drug delivery via liposomes using 
HIFU may integrate with HIFU surgery [18] in treatment of cancers. The ISPTA used here 
is lower than that (ISPTA ~1000 to 4660 W/cm2) used to cause tissue necrosis for cancer 
treatment for cancers [19]; it needs to be noted above-mentioned ISPTA was determined 
from data obtained from a water tank (free-field). Assuming that the same value ISPTA is 
needed in situ for in vivo applications, to get the in situ value of ISPTA equal to 900 W/cm2, 
depending on the depth of the target in tissue, the free-field intensity should be much 
higher. Using the average intensity attenuation coefficient of tissue μ= 0.2 NP/cm [18], 
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and the in situ intensity 0
xI I e μ−= , , here I is 900 W/cm2; assuming the full US passage 
distance = the focal length of the transducer, i.e.,x = 6.2 cm, it can be calculated I0 = 3110 
W/cm2. If US passes water for a distance before it enters the tissue, thus the tissue part of 
the US propagation distance x < 6.2 cm, I0 < 3110 W/cm2. Further in vivo studies are 
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Abstract 
It is known that there are many fine particles on the moon and Mars. Their existence may 
cause risk for the success of a long-term project for NASA; i. e., exploration and 
habitation of the moon and Mars. These dust-particles might cover the solar panels 
making them fail to generate electricity, and they might also penetrate through seals on 
space suits, hatches and vehicle wheels causing many incidents. The particles would be 
hazardous to human health if they were inhaled. Development of robust dust mitigation 
technology is urgently needed for the viable long-term exploration and habilitation of 
either the moon or Mars. We report here a feasibility study to develop a dust removal 
technique, which may be used in space-stations or other enclosures for habitation. It is 
shown experimentally that the acoustic levitating radiation force produced by a 13.8 kHz 
128 dB sound-level standing wave between a 3 cm-aperture tweeter and a reflector 
separated by 9 cm is strong enough to overcome the van der Waals adhesive force 
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between the dust-particles and the reflector-surface. Thus the majority of fine particles (> 
2 μm diameter) on a reflector surface can be dislodged and removed by a technique 
combining acoustic levitation and airflow methods. The removal efficiency deteriorates 
for particles of less than 2 μm in size.   
PAC numbers: 43.25. Gf, 43.25. Uv 
I. INTRODUCTION    
Exploration and habitation of the moon and Mars have become a long-term project 
for NASA (Calle et al., 2008). The presence of fine particles in Martian and lunar soil 
poses a significant threat to the success of the project. Since there is no water or other 
liquids in either environment, the mundane operation of washing away the fine 
particulates from any surface becomes impractical. The majority of particulates existing 
on the moon and Mars are silicon dioxides (SiO2). The particle-size range is broad; it can 
be as large as sub-millimeter and as small as 10 nm. It has been reported that transient 
dust clouds exists above the lunar surface even the atmosphere (mixture of H, He, Ar, Na 
and K) pressure is very low on the moon surface (Stern, 1999). It was suggested that the 
possible physical principle may be as follows: The dust particles on the moon may be 
electrically charged by charged particles from the solar wind as well as UV radiation 
(Horanyi, 1998). Consequently, levitation and migration of dust particles may take place 
near lunar surface. The solar panels brought to the moon during exploration by the 
astronauts, from which the electricity would be generated, may be quickly covered by 
dust particles making the electrical equipment nonoperational. Furthermore, the fact that 
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dust can penetrate through seals on space suits, hatches and vehicle wheels, etc. may also 
become troublesome. Furthermore, the lunar and Martian particles are hazardous to 
health by causing respiratory disease if they are inhaled (Schrunk et al., 1999); removal 
of dust particles from these surfaces should be important. 
Development of robust dust mitigation technology is urgently needed for the viable 
long-term exploration and habitation of either the moon or Mars. Such technology should 
be effective for dislodging particles of diameter ranging from 0.01-100 μm from a surface 
of a solar panel or space suits, etc. Existing dust mitigation technology, such as 
electrostatic precipitators and mechanical filters, either use large concentration of ions or 
require frequent filter changes or manual cleaning.  
It has been reported that lunar or Martian environment is very different from that on 
Earth. For example, more than 95% of Martian atmosphere is carbon dioxide. Mean 
surface level pressure is 600 Pa, only 0.6-0.7 % of the Earth atmosphere. The lunar 
atmosphere is even less significant in comparison with that of Mars and the Earth. 
Therefore, application of acoustic technique in an open space would be ineffective 
particularly for lunar applications. However, in a space station or an equivalent enclosure 
for exploration and habitation, the atmosphere condition should be very similar to that of 
the Earth. Thus the application of the acoustic method may provide an alternative surface 
cleaning technique.  
This study is designed to investigate the feasibility of using acoustic levitation 
method in dislodging dust from a dust-covered-surface possibly related to exploration 
and habitation of the moon and Mars. 
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II. THEORY 
A one-dimensional incident traveling plane-wave with frequency f and wavelength 
λ propagating along x direction (vertical downward as shown in Fig. 1) can be 
represented by )cos(),( 0 tkxutxu ω−= , where k = 2π/λ, ω =2πf, u(x, t) and u0 are 
instantaneous particle velocity and particle velocity amplitude respectively.  Now when 
we place a perfect plane reflector at x = L, perpendicular to the wave propagation 
direction and ignore the attenuation, letting the incident wave be superposed on another 
traveling wave traveling in the “-x” direction (reflected plane-wave), 0 cos( ),u kx tω+ we 
obtain a standing wave given by tkxuu ωcoscos2 0= . The boundary condition at the 
reflector (assuming the reflector is rigid) requires: 1( )
2
kL n π= + , i.e. ( 1 2) 2L n λ= + . 
Particle velocity antinodes (maxima) or pressure nodes are found when coskx = ± 1,  x 
= 0, λ/2,λ, 3λ/2, ….  Likewise, pressure antinodes (maxima) or velocity nodes are found 
where coskx = 0 at positions x = λ/4, 3λ/4, 5λ/4…. One of the acoustic pressure antinodes 
should locate at (2 1) ,
4
nx L λ += = where n are integers. The spacing between nearest 
pressure nodes or pressure antinodes is λ/2 (wavelength/2).   
The second order nonlinear effect of a sound field can produce a force on a particle 
in a fluid exposed to the sound field. The basis for such forces was expressed by Gor’kov 
(1962) in an equation for the acoustic radiation force on a spherical particle of volume v 
in a medium where the time averaged densities of the kinetic energy density <Ek> and 
potential energy <Ep> are known. Letting β be the ratio of the compressibility of the 
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particle material and the surrounding medium and ρs and ρo are the densities for the 
particle and the surrounding medium respectively, Gor’kov’s equation, applied to the x 
component Fx of the force, is  
Fx = v D dΦ/dx,   (1) 
where D = 3 (ρs - ρo) /(2ρs + ρo); Φ is called the acoustic force potential and is given by 
          Φ = <Ek> -  (1 - β) <Ep>.                             (2) 
Here the time-averaged kinetic energy < Ek > is proportional to the square of the particle 
velocity amplitude; since the velocity amplitude is just 2uo cos kx in the standing wave 
field, maxima of <Ek> occur one-half wavelength apart, i.e., when cos kx is equal to ±1. 
Since the net energy transported in a perfect standing wave is zero, it follows that 
d<Ep>/dx is equal and opposite to d<Ek>/dx. The dust particles are denser and less 
compressible than the surrounding fluid; for these, D > 1 and β < 1.  Hence Fx is in the 
direction of increasing <Ek> or decreasing <Ep>. In other words, theory predicts that 
when a plane standing sound wave is established in space, the dust-particles will migrate 
toward planes where  acoustic pressure amplitude is minimum, i.e., toward planes 
separated by a distance of λ/2 (one-half wavelength).   
We have used a circular rigid walled waveguide to couple with a sound source, a 
tweeter. For this type of waveguide of radius a, to satisfy the normal particle velocity 
being zero at r = a the acoustic pressures of possible modes may be written as (Kinsler et 
al. 1982) 
        ( )( ) cos( ) zi t k zml ml m mlp A J k r m e
ωθ −= ,                          (3) 







π⎛ ⎞= −⎜ ⎟⎝ ⎠                                          (4)  
and                                                                
 ' / ,ml mlk j a=                                                  (5)                
where 'mlj  is the lth root of  
( ) 0.mdJ x
dx
=    
The possible modes which can propagate in the waveguide excited by a sound 
source with circular symmetry and maximum vibration velocity amplitude at the center 
may be limited to m = 0 modes. For m = 0 and n = 1, it is a plane wave which can always 
propagate in the waveguide with a phase velocity c = 343 m/s in air at 20°C. In addition 
to this plane wave mode, it is possible to have the excitation frequency f of the acoustic 
source at z = 0, satisfying the following condition: 02 2ck π < f < 03 2ck π  (Kinsler et al. 
1982), the nonplanar (0, 2) mode may also propagate in the waveguide. Its mathematic 
expression is given by 
( )
02 0 02( ) ,z
i t k xp AJ k r e ω −=                                          (6)                
where 02 02' 3.83 .k j a a= =  For our application, a = 1.7 cm, c = 343 m/s (Kinsler et al., 
1982), 02 3.83 1.7 ,k cm= 03 7.02 1.7 ,k cm= 02 02 (2 ) 12.3f ck kHzπ= ≈ , and 
03 03 (2 ) 22.5f ck kHzπ= ≈ . Since the sound source has the highest transmitting efficiency 
at f = 13.8 kHz,  f =13.8 kHz was chosen for the excitation frequency to maximize the 
acoustic radiation force, which is between 02f  and 03f . The (0, 2) mode phase velocity 
2
,02 021 ( ) 756pc c f f= − = m/s and its wavelength along the propagation direction 
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02 ,02 / 5.48pc fλ = = cm (Kinsler et al., 1982). For the planar wave, 2.48c fλ = = cm. 
III. EXPERIMENTAL METHODS AND RESULTS 
The main experimental setup (Fig 1.) consists a tweeter as a sound source 
(KSN-1188A, CTS, Elkhart, IN) coupled with a cylindrical waveguide, a plane reflector, 
loaded with Mars (JSC Mars-1A, Planet LLC，Madison, WI ) or lunar (JSC-1A, Planet 
LLC，Madison, WI ) dust simulants, installed perpendicular to the acoustic axis of the 
tweeter by keeping (9 0.1)L = ± cm, and a color CCD camera (STC-H630, SENTECH, 
Carrollton, Texas) used to monitor the movements of the dust simulants. The sinusoidal 
electric signal of 13.8 kHz generated by  a function generator (HP 3325, Hewlett 
Packard, Palo Alto, CA) and amplified by an  audio power amplifier  (Sony 
STR-K660P amplifier, New York, NY) was applied to the tweeter to establish a standing 
wave field between the tweeter and reflector. A ¼” microphone (model 4133, Brüel & 
Kjær, Denmark) coupled with a hollow 2mm diameter metallic tube (Fig. 1) and 
associated preamplifier was used to measure sound pressure amplitude as a function of 
axial distance from the reflector. The output of the preamplifier was connected to the 
input of a digital oscilloscope (54641A, Agilent Technology, Palo Alto, CA). Activities of 
the dust particles on the reflector were monitored through the CCD camera with a lens 
system (Vivitar Series 1, 70-210mm, Vivitar Co., Edison, NJ). A video capture card 
(Cx2388x, Harmonics, Newport Beach, CA,) was used to capture the video signals which 




Fig. 1. Illustration of experimental setup (not scaled). 
 
 
Fig. 2. Microphone measurements. Left: Acoustic pressure amplitude between the tweeter 
without cylindrical waveguide and silicon wafer.  Right:  Acoustic pressure amplitude is 
significantly improved by using a cylindrical waveguide coupled to the tweeter. 
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The acoustic pressure amplitude was measured spatially every 0.5cm step upwards 
from the reflector. The best-fit solid curve for the acoustic pressure amplitudes vs the 
distance between the reflector and tweeter was obtained using the “Spline” mode of a 
software (Origin 6.0,OriginLab Corporation, Northampton, MA) as shown in Fig. 2 (left 
panel); it suggests a standing wave acoustic field was established in space. To further 
enhance the acoustic field, a cylindrical lucite waveguide (8 cm long, 3.4 cm diameter) 
was then closely coupled to the tweeter. The axial acoustic pressure amplitude near the 
reflector surface was measured and was found to be significantly enhanced by about 6 
fold or by 15.6 dB magnification as show in Fig. 2 (right panel). Due to the presence of 
the waveguide, the space limitation only allowed us to measure acoustic pressure 
amplitude in a small region near the reflector where the waveguide was terminated. We 
expected the similar enhancement would take place within the waveguide. The spatial 
averaged acoustic intensity over ¼” diameter cross-section was estimated by using a ¼” 
sound level meter with the linear mode setting (Model 215, Quest Electronics, 
Oconomowoc, Wisconsin). The spatial-averaged acoustic intensity generated by the 
tweeter with the cylindrical waveguide was 128 dB, 8 dB higher than that without the 
waveguide. The waveguide played a role of concentration of sound energy in space and 
also altered the wavelength as it left the waveguide and propagated into open-space as 
described by Eq. 4 and demonstrated by the right panel of Fig. 2. It was observed that the 
majority of dust particles were levitated in the acoustic standing wave field. It is 
suggested that the acoustic radiation force was strong enough to overcome gravity of the 
particle and the adhesive van der Waals force between the particles and reflector surface. 
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We then turned on the air flow generated by a small fan (diameter 13.5cm). The dust 
particles were quickly blown away after they were levitated from the surface. Without the 
acoustic field, the airflow alone had no effect on the dust particles lodged on the reflector 
surface due to the strong van der Waals force. 
 
Fig. 3. Photos of four reflector surfaces of 9 cm x 9 cm size made of different materials :  silicon 
wafer, commercial solar panel, synthetic leather and Teflon. 
 
We studied the particle remove efficiency on 4 different reflectors of 9×9 cm2 size 
made of different materials:  silicon wafer, commercial solar panel, synthetic leather and 
Teflon as shown by Fig. 3. All these 4 different reflectors were placed on top of an 
aluminum square block (10×10 cm2). All parameters including L, frequency and acoustic 
intensity were kept the same for all four materials. Each reflector was exposed to the 
acoustic excitation and air flow for 90 seconds during the removal operation. Size 
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distributions of the residual particles after removal on the reflectors were studied by 
direct counting using a microscope (Nikon LABOPHOT-2, Nikon Instruments Inc., 
Melville, N.Y.). 
Figure 4 contains 6 images taken in sequence when silicon wafer was chosen as the 
reflector. Arrow represents the air flow direction. Air flow was continuously on for all 6 
images were taken and acoustic signal was continuously turned on starting at images 2. 
There was no particles’ movement at the time when image 1 was taken when only air 
flow was on. Particles began to be removed as soon as the tweeter was turned on as 
shown in images 2-6. Mars dust simulants were removed effectively by the air flow after 
they were levitated by the standing wave acoustic field. 
 
 
Fig. 4. Mars dust simlulants lodged on the silicon wafer were removed by air flow after they 
were levitated in a standing acoustic field.  The airflow had no effect on the dust-particles 




Fig. 5. Typical microscopic images of (A) Mars and (B) lunar dust simulants accompanied with   
the percent-number size-distribution histograms shown on their right. 
 
Figure 5(a) and 5(b) are typical microscopy images of Mars and lunar dust simulants 
accompanied with the percent-number size-distribution histograms shown on the right. 
The histograms of Mars and lunar dust simulants indicate that they both have a large 
component of particles with diameter less than 6μm, specially in the 2-4μm range. The 
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percent-number of Mars dust stimulants for > 4μm is about 25 % and that for 2μm < 
particle-size < 4μm is about 45 %. The lunar dust simulant has a similar  
percent-number (12% vs 14%)as the Mars dust simulant in the size range >4μm, a bit 
lower percent-number (40% vs 45%) in the size range 2μm -4μm, and it has more 
particles in the range < 2μm (38%) than Martian dust simulant has (29%).  For further 
experimental tests, we decided that only Martian dust simulants would be used. 
The dust-particle removal efficiencies for the four target-reflectors are illustrated by 
figure 6. There are 3 panels for each of Fig. 6(a)-6(d); the first two are photos of a 
reflector covered by Mars dust simulant taken under the microscope before and after the 
dust-simulants removal operation by air flow and acoustic standing wave, the third panel 
on the right is the size distribution histogram of the particles residual on the reflector after 
the removal procedure. Few particles larger than 4μm were left (from more than 25% 
before the operation to less than 9% after the operation) on the silicon wafer, solar panel 
and synthetic leather after the removing operation as shown in Fig. 6(a)-6(c). 
Particle-number in the range of 2-4μm was also dramatically reduced from 46% to 
around 20% on silicon wafer and 15% on the solar-panel and leather surfaces. Small 
particles whose size was less than 2μm dominated in the residuals.  When Teflon was 
used as the target-material, the particle-removal efficiency decreased significantly as 
shown in Fig. 6(d). However, we were still able to see Mars dust simulants bouncing 
around on the Teflon material under the excitation of acoustic standing wave. But due to 
the loose nature and surface roughness of the fabric texture a lot of large and small 
particles were trapped in the texture. 
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Fig. 6. Dust-particle removal efficiencies for the four target-materials (silicon wafer, commercial 
solar panel, synthetic leather and Teflon). (Color on line) 
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Fig. 7. Solar panel voltage output vs time.  At t = 25 s, the Mar dust simulants were spreaded on 
the solar panel and output voltage dropped from 3.0 V to 0.4 V.  At t = 90 s, the tweeter and the 
airflow were tuned on.  As the dust particles were removed, the output voltage gradually 
recovered to 2.95 V.  With the air flow alone, no effect was observed. 
 
Figure 7 shows the solar panel output voltage measured by a Digital Multi-meter 
(Model 2000, Keithley Instruments, Inc., Cleveland, Ohio) as function of time. It reflects 
the voltage output changed with time as the Mars dust simulants were sprayed on the 
surface and gradually removed from it by the combination of acoustic standing wave 
effect and airflow method. There was a significant drop in solar panel output voltage 
(below 15% of its initial voltage) due to the deposition and coverage of Mars dust 
simulants. The output voltage remained constant in time until the air flow and acoustic 
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field were applied at t = 90 s. The output-voltage of the solar panel restored quickly to 
around 65% in the first 20 seconds, then increased gradually up to 98.4% after 4 minutes 
and no further improvement could be observed. 
IV. SUMMARY AND DISCUSSION 
Our feasibility study has shown that the majority particles of the dust simulants can 
be levitated from a surface by the radiation force due to a standing-wave acoustic field. It 
has been observed that significant reduction of Mars dust simulants lodged on the target 
surfaces of silicon wafer, solar panel and synthetic leather few minutes after using the 
acoustic technique incorporated with air flow. It has also been observed that the 
efficiency becomes lower for submicron size particles’ removal from a target. As shown 
in our previous work (Wu and Du, 1990), acoustic radiation force is proportional to the a3 
(a is particle radius). For smaller particles, the acoustic radiation force becomes too weak 
compared to the strong adhesive van der Waals force between the particles and the 
target-surface. 
Equation 1 suggests that the radiation force is proportional to the gradient of 
acoustic force potential Φ. In order to increase the radiation force, it is advantageous to 
increase the frequency or decrease the wavelength. On the other hand, the acoustic 
attenuation increases with frequency. It was found experimentally the sound source 
(tweeter) has highest transmitting efficiency near 13.8 kHz. Thus, f = 13.8 kHz was 
chosen for the excitation frequency. Another advantage for the higher frequency (> 10 
kHz) is that human ears are less sensitive above 10 kHz, therefore high amplitude ten 
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kHz sound wave would cause less annoyance than the same sound level of kHz sound 
waves.    
As discussed earlier, the possible modes propagating in the waveguide which can be 
excited by a sound source with circular symmetry and maximum vibration velocity at the 
center may be limited to m = 0 modes. Since experimentally we found the sound source 
has the maximum transmitting efficiency at frequency of 13.8 kHz, we chose 
13.8f = kHz for the excitation frequency, which is between f02 and  f03. There should be 
a wave that is superposition of a planar (0, 1) wave and a nonplanar (0, 2) wave 
propagating in the waveguide. If it were a pure planar wave, 2λ = c/2f = 
34300/(2 × 13800) = 1.24cm. For (0, 2) mode, 02 ,02 /(2 ) 2.74pc fλ = = cm.  
Experimentally, the location of the reflector (L = 9 cm) was determined by maximizing 
levitation effect (maximizing the acoustic radiation force) during the experiment. 
According to the planar waveguide theory described earlier, the distance between the 
source and the pressure antinode L is given by (2 1) / 4.L nλ= + Thus 
/ 2 /( 1/ 2)L nλ = + = 9 cm/(7.5)=1.20 cm when n = 7. The fact that the error incurred for 
the measured wavelength compared with the pure planar wave being quite small, equal to 
(1.24-1.20)/1.24 3%≈ , implies that the reflector’s location by maximizing the levitation 
force was nearly at one of the pressure antinodes of a standing wave generated by 
superposition of the pure planar wave and its reflection. It suggests that in the waveguide 
of our experiment, the planar wave may dominate. Strictly speaking, the velocity 
amplitude being 2uo cos kx in a standing wave field from Gor’kov’s equation was based 
on a plane wave assumption. Theoretical modification might be needed to the current 
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experimental situation since the wave was no longer a pure planar wave. On the other 
hand, as suggested by above argument, the planar wave might still dominate in our 
experiment, so it might still approximately be considered a planar wave. 
As stated earlier, this study was performed under the Earth atmosphere condition.  
The technique may be limited to be applied in a space station or other enclosures for 
habitation. The condition on the moon and Mars are quite different. In order to use it in 
an open space, a gas tank is needed to be bought there and the 
tweeter-waveguide-reflector system needs to be sealed. 
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The purpose of the research described in this dissertation was to satisfy the 
following research objectives: (1) to study the behavior of liposome in comparison with 
an ultrasound contrast agent (Optison®) in the sonoporation process; (2) to investigate the 
feasibility of inducing drug release from nanometer-sized drug encapsulated lipsomes by 
ultrasound; (3) to investigate the feasibility of using acoustic levitation method to remove 
fine dust particles from a dust-covered-surface with minimal surface abrasion. As 
described in chapter 2, 3 and 4, these investigations have been carried out and the 
conclusions are summarized below. 
Firstly, our preliminary experimental results have shown that liposomes synthesized 
in our laboratory were quite stable under the sonication; liposomes can sustain 40 s of 
ultrasound exposure (2.2 MHz and the in situ spatially averaged and temporally averaged 
intensity ISATA was 80W/cm2), while many Optison® spheres would rupture and disappear 
under 20s of the same ultrasound exposure. It has also been experimentally shown that 
liposomes like Optison® were able to assist ultrasound to deliver antibodies into Jurkart 
cells. The sub-harmonic component of the scattering signal from the liposome samples 
during the sonication suggests acoustic cavitation did occur in sonoporation process with 
the presence of liposomes and liposomes in this case might serve as cavitation nuclei. 
Although the antibody delivery efficiency by using liposomes is lower than that when 
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Optison® spheres were used, the improvement of liposome preparation method and 
optimizing acoustic parameters may enhance the efficiency in future. Further studies on 
the delivery mechanisms are certainly needed as well. 
Secondly, a method to synthesize nanometer-sized liposome (<300nm) is introduced. 
Our in vitro study demonstrated that high intensity focused ultrasound (HIFU) is capable 
of effectively inducing leakage of contents from this type of nanometer-sized liposomes 
with an average diameter of 210 nm in a short period of irradiation. The release kinetics 
of the encapsulated fluorescent materials (FITC) suggests the content release efficiency 
up 70 % from liposomes in the suspension can be obtained after 60 s’ sonication by US of 
ISPTA = 900 W/cm2.  The transmission electron microscopy (TEM) images of liposomes 
revealed the strong effect of HIFU on the liposome membrane as the main cause of the 
drug release. The destructive effect of the HIFU to the nanometer-sized liposomes and the 
presence of a strong subharmonic spectrum suggest inertial cavitation might dominate in 
the sonication process and liposomes might play a role as cavitation nuclei. The fracture 
of relatively large liposomes (>100nm) and generation of pore-like defects in the 
membrane of small liposomes might be the predominant mechanisms of encapsulated 
content released from liposomes.  
The potential clinical applications of the targeting drug delivery via liposomes using 
HIFU may integrate with HIFU surgery in treatment of cancers. The ISPTA used here is 
lower than that (ISPTA ~1000 to 4660 W/cm2) used to cause tissue necrosis for cancer 
treatment for cancers. But the above-mentioned ISPTA in this study was determined from 
data obtained from a water tank (free-field). To get the in situ value of ISPTA equal to 900 
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W/cm2, depending on the depth of the target in tissue, the free-field intensity should be 
much higher. Further in vivo studies are certainly needed to determine the in situ value of 
ISPTA required to release the content of liposomes in vivo. The great enhancement of 
HIFU-mediated release in the nanometer-sized liposomes may prove useful for 
preclinical and clinical applications. 
Thirdly, it has been experimentally shown that the acoustic levitating radiation force 
produced by a 13.8 kHz 128 dB sound-level standing wave between a 3 cm-aperture 
tweeter and a reflector separated by 9 cm is strong enough to overcome the van der Waals 
adhesive force between the dust-particles and the reflector-surface. Significant reduction 
of Mars dust simulants lodged on the target surfaces of silicon wafer, solar panel and 
synthetic leather few minutes after using the acoustic technique incorporated with air 
flow was observed. The removal efficiency deteriorates for particles of less than 2μm in 
size, because acoustic radiation force is proportional to the a3 (a is particle radius), for 
smaller particles, the acoustic radiation force becomes too weak compared to the strong 
adhesive van der Waals force between the particles and the target-surface. This study was 
performed under the Earth atmosphere condition.  The condition on the moon and Mars 
are quite different, thus, the technique may be limited to be applied in a space-stations or 
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APPENDIX A     
LIPOSOME SYNTHESES 
A.1 Routine liposome  
Phosphatidylcholine (PC), stearylamine(SA), and cholesterol (CH) were purchased 
from Sigma Chemicals (Sigma Chemical Co., St. Luis MO).  Routine reagents and 
solvent were of analytical grade. 
Component lipids of PC, SA and CH, totaling 350mg, were mixed in the mole percent 
ratio of 65:5:30 and dissolved in 10ml of chloroform in a round-bottomed flask. The 
chloroform solvent was removed by evaporation under reduced pressure using a rotary 
vacuum evaporator (Buchi Rotavapor R-200, BÜCHI Labortechnik AG Meierseggstrasse 
40 Postfach CH-9230 Flawil 1 Switzerland). Lipid film was hydrated with 35 ml 
deionized water to yield a concentration of 10 mg lipid/ mL by continuous votex-mixing 
of the flask. The rehydrated mixture in a plastic culture tube of 10 mm diameter and 75 
mm length (Kimble, Owens-Illinois, Toledo, OH) was sonicated with 20 kHz ultrasound 
for 2 minutes with a power of 12W (reading from the system) using the microprobe of a 
sonicator (Misonix Sonicator 3000, Misonix, Inc. New Highway Farmingdale, NY, USA). 
After this process the lipid suspension formed a milky solution of liposomes. 
A.2 FITC-encapsulated liposome 
1, 2-Diacyl-sn-glycero-3 phosphocholine (PC) (Sigma-Aldrich, St. Louis, MO, USA) 
and 1,2-Dipalmitoyl-sn-Glycero-3-Phosphoethanolamine-N-[Methoxy (Polyethylene 
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glycol)-2000] (PEG2000-DPPE) (Avanti Polar Lipidsm, Inc., Alabaster, AL, USA) were 
mixed to the mole percent ratio of 95:5 and dissolved in chloroform in a round-bottomed 
flask. The chloroform solvent was removed under N2 using a rotary evaporator to 
generate a lipid film attached to the inner flash wall. Amount of 0.1 mg/mL FITC solution 
was made by dissolving the FITC powder (Sigma-Aldrich, St. Louis, MO, USA) in 
phosphate buffered saline (PBS) solution (pH 7.4). Appropriate amount of FITC solution 
(0.1 mg/mL) was added to the flask to rehydrate the lipid film to a concentration of 5 mg 
lipid/mL by continuous vortex-mixing of the flask for 3 hours in a 70ºC water bath. A 
milky solution of liposome was obtained subsequently. Some of the FITC solution was 
encapsulated inside the liposomes during the swelling of the lipid film. The liposome 
solution was distributed to plastic culture tubes (12 x 75mm, VWR, West Chester, PA, 
USA) by 1mL in each. The fluorescent light coming out from the test tube was too strong 
to be detected optically when the sample was observed by using a fluorescent microscope. 
To avoid saturation, we needed to reduce the fluorescent light intensity from the solution. 
The sample in the test tube was diluted two times.  For each dilution, the sample 
solution was first made uniformly distributed in a test tube by a vortexer (model: G-560, 
VWR,West Chester, PA,USA). Then we replaced the top half solution in each tube by 0.5 
mL PBS.  After two dilutions, the fluorescent light intensity reduced to about ¼ of the 
initial value. These samples were ready to be sonicated. The average fluorescein (FITC) 
encapsulated in the liposome was much higher than that in the solution, the fluorescent 
intensity in the solution would increase if rupture of or leakage from liposomes was 
induced under the irradiation of US.  
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APPENDIX B    
DYNAMIC LIGHT SCATTERING TECHNIQUE 
Dynamic light scattering (DLS) is also known as Quasi-Elastic Light Scattering 
(QELS) or Photo Correlation Spectrocopy (PCS). Its fundamental physical principle is to 
measure the intensity of light scattered by the molecules/microscopic particles in the 
sample as a function of time. When light generated by a laser is scattered by a molecule 
or particle some of the incident light is scattered. If the molecule was stationary then the 
amount of light scattered would be a constant. However, since all molecules in solution 
diffuse with Brownian motion in relation to the detector there will be interference 
(constructive or destructive) which causes a change in light intensity (Figure B. 1). By 
measuring light intensity fluctuations as a function of time, DLS can provide information 
regarding the average size, size distribution, and polydispersity of molecules and particles 
in solution. 
   
Figure B. 1. Left: Constructive Interference; Right: Destructive Interference. Adapted from 
http://www.chemeurope.com.  
 
Normally DLS is concerned with measurement of particles suspended within a 
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liquid. Brownian motion is the random movement of particles due to the bombardment by 
the solvent molecules that surround them. The larger the particle, the slower the 
Brownian motion will be. An accurately known temperature is necessary for DLS 
because knowledge of the viscosity is required (because the viscosity of a liquid is related 
to its temperature). The temperature also needs to be stable, otherwise convection 
currents in the sample will cause non-random movements that will ruin the correct 
interpretation of size. The velocity of the Brownian motion is defined by a property 
known as the translational diffusion coefficient (D). The size of a particle is calculated 
from the translational diffusion coefficient by using the Stokes-Einstein equation; 
( ) 3d H kT Dπη=  
where:    d(H) = hydrodynamic diameter 
D = translational diffusion coefficient 
k = Boltzmann’s constant 
T = absolute temperature 
η = viscosity 
Note that the diameter that is measured in DLS is a value that refers to how a 
particle diffuses within a fluid so it is referred to as a hydrodynamic diameter. The 
diameter that is obtained by this technique is the diameter of a sphere that has the same 
translational diffusion coefficient as the particle. The translational diffusion coefficient 
will depend not only on the size of the particle, but also on any surface structure, as well 
as the concentration and type of ions in the medium.  
If the particles are small compared to the wavelength of the laser used, then the 
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scattering from a particle illuminated by a vertically polarized laser will be essentially 
isotropic, i.e. equal in all directions. The Rayleigh approximation tells us that 6I d∝  and 
also that 41/I λ∝ , where Ι = intensity of light scattered, d = particle diameter and λ = laser 
wavelength. The 6d  term tells us that a 50nm particle will scatter 106 or one million 
times as much light as a 5nm particle. Hence there is a danger that the light from the 
larger particles will swamp the scattered light from the smaller ones. This 6d  factor also 
means it is difficult with DLS to measure, say, a mixture of 1000nm and 10nm particles 
because the contribution to the total light scattered by the small particles will be 
extremely small. The inverse relationship to 4λ  means that a higher scattering intensity 
is obtained as the wavelength of the laser used decreases. 
For a system of particles undergoing Brownian motion, a speckle pattern is observed 
where the position of each speckle is seen to be in constant motion. This is because the 
phase addition from the moving particles is constantly evolving and forming new patterns. 
The rate at which these intensity fluctuations occur will depend on the size of the 
particles. Figure B. 2 schematically illustrates typical intensity fluctuations arising from a 
dispersion of large particles and a dispersion of small particles. The small particles cause 
the intensity to fluctuate more rapidly than the large ones.  
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Figure B. 2. Typical intensity fluctuations for large and small particles adapted from 
http://en.wikipedia.org/wiki/Dynamic_light_scattering 
 
It has been seen that particles in a dispersion are in a constant, random Brownian 
motion and that this causes the intensity of scattered light to fluctuate as a function of 
time. The correlator used in a DLS instrument will construct the correlation function G (τ) 
of the scattered intensity: 
( ) ( ) ( )G I t I tτ τ= 〈 ⋅ + 〉  
where τ is the time difference (the sample time). Basically a correlator is a signal 
comparator. It is designed to measure the degree of similarity between two signals, or one 
signal with itself at varying time intervals. For a large number of monodisperse particles 
in Brownian motion, the correlation function (G (τ)) is an exponential decaying function 
of the correlator time delay τ: 
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2( ) [1 exp( 2 )]G A B Dqτ τ= + −  
where A is the baseline of the correlation function, B is the intercept of the correlation 
function, D is the diffusion coefficient, 0(4 / )sin( 2)q nπ λ θ= , where n is refractive 
index of dispersant, 0λ is wavelength of the laser, θ  is the scattering angle. For 
polydisperse samples, the equation can be written as: 
2( ) [1 ( ) ]sG A BGτ τ= +  
where ( )sG τ  is the sum of all the exponential decays contained in the correlation 
function. Once the correlation function G (τ) has been plotted (normally on a log scale 
time base), then the hydrodynamic diameter can be determined by the Stokes-Einstein 
equation ( ) 3d H kT Dπη= . 
The size information can be obtained from the correlation function by using two 
approaches: (1) fit a single exponential to the correlation function to obtain the mean size 
(z-average diameter) and an estimate of the width of the distribution (polydispersity 
index), (2) fit a multiple exponential to the correlation function to obtain the distribution 
of particle sizes. The size distribution obtained is a plot of the relative intensity of light 
scattered by particles in various size classes and is therefore known as an intensity size 
distribution.  
The process to determine the hydrodynamic diameter and size distribution of 
particles in a solution by using DLS technique is shown in a flowchart (Figure B.3). The 
theoretical limit of this technique is that species of less than 40% difference in size cannot 
be resolved. However, in practice a factor of 2-3x can be required. If full resolution is 
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necessary the sample must be physically separated by centrifugation, filtration, HPLC or 
field flow fractionation techniques. 
 
Figure B. 3. Determination of the size information of particles in solution by DLS technique 
